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THE DEVELOPMENT OF A SYSTEMATIC DISCHARGE PLANNING PROCESS

FOR THE CARE OF COPD PATIENTS IN A SMALL URBAN COMMUNITY

HOSPITAL
MICHELE A. BARTON-VERDI
ABSTRACT
Background: Several attempts have been made to examine factors that influence

30-day readmissions in a hospital setting to ensure that inpatient care is accompanied by
an effective post-discharge plan that can decrease 30-day readmissions to guide hospitals

to use practices that increase hospitals ‘quality implications (Shah et al., 2015; Kripalani

et al., 2007; Rinne et al., 2017, Jenks, Williams and Coleman, 2009, Shah, Press,
Husingh-Scheetz & White, 2016; Sickler et al., 2015; Pruitt, 2018; Hansen et al., 2013;
Simmering et al., 2016; Alper, O’Malley, & Greenwald, 2019). Purpose: To determine

the role of post-discharge care in 30-day readmissions along with the typical clinical
outcomes identified, we examined a small urban hospital population and the patient

characteristics in each post-discharge care setting (HSC, HHC, LTAC, and SNF).

Patients and Methods: A retrospective study was conducted in patients with COPD
hospitalizations using the data from a small urban community hospital from 2014 to

2019, n = 1,008. Results: Home health care was identified as having the highest
readmission rate in this small urban community hospital using a test of proportions. The
weighted variables from a researcher-developed covariate scoring table were analyzed
using a Chi-square analysis. The findings provided a reference framework for a

systemized discharged planning process according to how the variables/groups were
scored.
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LIST OF DEFINITIONS
Ambulatory - individual is able to walk about and not be bedridden (Meriam Webster,

2019)
Comorbidity - existing simultaneously with and usually independently of another
medical Condition (Meriam Webster, 2019)
Continuum of Care - “a concept involving a system that guides and tracks patients over
time through a comprehensive array of health services spanning all levels and intensity of

care. Covers the delivery of healthcare over a period and may refer to care provided from

birth to end of life” (Centers for Medicare & Medicaid Services (CMS), 2019).
Discharge - to relieve of a charge, load, or burden (Meriam Webster, 2019)

Exacerbation - to make more violent, bitter, or severe (Meriam Webster, 2019)

Health literacy - “the ability to read, understand and act on health care information” (US
Department of Health and Human Services, 2000).

Home Bound - “You need the help of another person or medical equipment such as

crutches, a walker, or a wheelchair to leave your home, or your doctor believes that your
health or illness could get worse if you leave your home, and it is difficult for you to
leave your home and you typically cannot do so” (Centers for Medicare & Medicaid

Services (CMS), 2019).
Hypercapnia/ Hypercarbia - having an abnormally high concentration of carbon
dioxide in the blood (Meriam Webster, 2019)

Hypoxemia - having low oxygen content in the blood (Meriam Webster, 2019)

Hypoxia - having low oxygen supply in the bodily tissues (Meriam Webster, 2019)

xv

Index Admission - “the admission with a principal diagnosis of a specified condition
that meets the inclusion and exclusion criteria for the measure (Centers for Medicare &

Medicaid Services” (CMS), 2019).
Multimorbidity - the presence of multiple chronic conditions (Zulman et al., 2013).
Overdiagnosis - the diagnosis of a condition or disease more often than it is present

(Meriam Webster, 2019)

Post-Acute Care - “includes rehabilitation or palliative services that beneficiaries

receive after, or some cases, instead of, a stay in an acute care hospital. Depending on
the intensity of care the patient requires, treatment may include a stay in a facility,
ongoing outpatient therapy, or care provided at home (Centers for Medicare & Medicaid

Services” (CMS), 2019).
Post-discharge Care - care occurring after discharge from a hospital (Centers for

Medicare & Medicaid Services, 2019).
Purulent - consisting of, containing, or discharging pus (Meriam Webster, 2019)

Readmission - a second or subsequent admission (Meriam Webster, 2019)

Underdiagnosis - to diagnose (a condition or disease) less often than it is present.
(Meriam Webster, 2019
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CHAPTER I

INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is currently the fourth leading

cause of death in the United States and is close to becoming the third leading cause of
death (Centers for Disease Control and Prevention, 2018). Approximately seventy

percent of the 24 million with a COPD diagnosis are under the age of 65. COPD resulted
in almost $50 billion in indirect/direct costs in 2016 (Guarascio, Ray, Finch & Self,

2017). It is estimated that as much as 60% or more of patients with respiratory symptoms
readmit within 30 days back to the hospital and were not initially diagnosed with COPD,

especially with the mild to moderate classification (Diab et al., 2018). There is also a
high occurrence of overdiagnosis because of patients diagnosed with COPD based on
symptoms and rather than a measurement of how well their lungs work (Diab et al.,

2018). Nationally, for those patients diagnosed with COPD, 22.8% are readmitted to the
hospital within 30 days of their indexed admission and this is associated with significant

health care expenditures (Shah et al., 2015). The literature identifies that 10 to 55% of
readmissions for an acute exacerbation of COPD may be prevented (Centers for Disease

Control and Prevention, 2021).

Post-acute care/post-discharge care providers (home health care agencies, skilled
nursing facilities, long-term acute care hospitals, and pulmonary rehabilitation) provide

the opportunity to recover and rehabilitate after an acute care hospital stay. Premature
discharge or release to an environment that is not capable of meeting the patient’s

medical needs may result in hospital readmissions within 30-days (Alper, O’Malley &
Greenwald, 2019).

Ensuring that an engaging post-discharge care plan accompanies inpatient care

can decrease excess healthcare use and increase quality implications for hospitals. Table
1.1 defines the most frequently used care settings that patients may be referred to upon

discharge. Based on the patient’s needs, effective discharge planning provides the
continuity of care between the healthcare facility and the community. It has been

described as the critical link (Kangovi & Grande, 2014). The discharge plan’s goal is to
reduce hospital length of stay and unplanned readmission to the hospital and also to
advance the coordination of services following discharge from a hospital (Naylor &
Keating, 2008).
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Table 1.1 Post-Acute/Post-Discharge Settings Variables Defined

Definitions (Centers for Disease
Control and Prevention, 2018)
Those patients with a chronic illness that
have metabolic, endocrine, physiologic,
and immunologic problems that may have
respiratory failure and need hospital-level
care for an extended period time.
Patients that need short-term skilled care
nursing or rehabilitation service on an
inpatient basis following a hospital stay.
Patients are confined to their homes and
need skilled care (from a nurse, physical,
occupational or speech therapist) on a
part-time basis.
Patients are discharged to home without
any organized care (To be included from
data in home with self-care category:
discharged to court, group home, or a
halfway house.

Post-Acute Care/Post-Discharge Care
Long-Term Acute Care Hospital
(LTAC)

Skilled Nursing Facility (SNF)

Home Health Care (HHC)

Home with Self-Care (HSC)

Background
Managing COPD patients continues to challenge health care systems, and
challenges directly impact the financial performance of hospitals because the Centers for

Medicare and Medicaid impose penalties on hospitals with excessive COPD readmissions
(CMS, 2019), evidenced-based interventions are needed.

The results of a COPD exacerbation include a discouraging impact on the quality

of life, accelerated lung function decline, increased symptoms and impaired lung
function, increased economic costs and, increased mortality. Care does not end when a

patient ambulates or is wheeled out the door. The hospital’s appropriate discharge care

needs to be systematically identified to ensure the proper continuum of care.
Currently at the small urban community hospital (SUCH), patients are admitted

mostly through the emergency department, some may be a direct admit from a

3

Physician’s office at SUCH. Any patient who is admitted to the hospital in respiratory

distress and/or has shortness of breath, cough and sputum is normally given the basic
COPD management regimen and then reevaluated to determine if they will be discharged
from the emergency room or admitted to the hospital. Upon admission to the internal

medicine floor or the intensive care unit (ICU) the admitting physician has 24 hours to

visit the patient and decide what medications need to be started and perform a medication
reconciliation of the medications a patient is taking at home, and to determine if those

medications need to continue or temporarily stopped. Upon discharge medications will be
reconciled and it will then be determined which medications will be restarted or added to

their home regimen (Wolfe, 2020).
The management of a patient with COPD depends on the background of the
physician and their familiarity with the patient. Currently there are order sets at SUCH
depending on how the patient’s diagnosis is documented. The order sets are clinical

decision support tools that help the physicians prescribe the appropriate treatment for
COPD, including applicable medications and the recommended dosages from evidence

based guidelines for COPD. Currently, there is not a systematic process that would alert
the case management team or discharge administrator to aid in the early preparation or

care transition process that would notify healthcare workers that an individual could be at
high risk for readmission with certain identifiable factors (Wolfe, 2020).

Discharge assistance for COPD patients is crucial to minimize the impact of
future readmissions (Kripalani et al., 2007). Identifying the best alternatives in post
discharge care for patients based on severity of the disease can give a patient the option to

go home and care for themselves, which is referred to home with self-care (HSC), or be
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referred to a suggested post-discharge care (HHC, SNF, or LTAC). A patient may be

provided the option of having home health care (HHC) receiving rehabilitation services
(occupational/physical therapy and nursing care) in their home. Some patients with more

severe COPD may be sent to a skilled nursing facility (SNF) or a long-term acute care
facility (LTAC) (Foster et al., 2007). After patients are discharged from inpatient care
(HHC, SNF or LTAC) they can be referred to a supervised exercise training program that

includes health education, breathing techniques, and specific instructions for the patient’s

self-management to prevent future relapses (Johnston & Grimmer-Sommers, 2010).

Rationale and Significance
The issue that inspired this project was the high incidence of patients discharged
from the hospital with a COPD diagnosis readmitted back to the hospital within 30 days

more in different discharge care dispositions. Without the proper classification of the
severity of COPD, assessment, and health status measurement, and facilitation of early

mobilization of post-discharge care, hospitals may not use the best available options that
are in the best interest of each individual COPD case, and patients may readmit back to

the hospital within 30 days (Burge & Wedzicha, 2003).
With COPD approaching the third leading cause of death globally, the estimated

cost for treatment is $7,100 per patient a year in the United States (Portillo et al., 2018).

The cost of a readmission of COPD within 30-days is approximately can be significantly

higher than the initial stay costing $9,000 to $12,000 on average (Press, Konetzka &
White, 2018). The risk of readmission for COPD within 30 days is over 22%. There is a
55% mortality rate and 44% rehospitalization risk within 5 years of hospital discharge

(McGhan et al., 2007). The risk of rehospitalization within 30-days of COPD patients
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increases with the number of comorbidities, previous hospitalizations, ethnicity, diabetes

and hypertension (McGhan et al., 2007).
The quality-of-care is lacking in many aspects of patient care of those with
COPD. The Centers of Medicare and Medicaid instituted penalties for 30-day

readmissions in October 2014 as part of the Hospital Readmission Reduction Program
(HRRP) (Centers for Medicare & Medicaid Services (CMS), 2018). Some of the risk

factors that are not adjusted for with the accountability of the CMS system include: race,
socioeconomic status, health related quality of life, cognitive impairment, severity of

illness, health literacy, caregiver support and access to care (Feemster & Au, 2014).
There is not an adjustment in penalties for those hospitals caring for disadvantaged
patients (Shah et al., 2015). For those institutions with fewer resources, they are not held

to a different standard. Hospitals that care for the sickest and poorest patients are at the

most risk for penalties. Teaching hospitals in urban areas that provide care to those with
complex medical problems are most likely to have HRRP penalizations (Shah et al.,

2015).

There have not been any published programs that are evidenced based to reduce
30-day hospital readmissions with COPD patients that have been proven to be effective
(Rinne et al., 2017). The events and circumstances that could potentially predict 30-day

readmissions take place outside the hospital environment especially with those that have

severe illnesses and with the socioeconomically disadvantaged populations which lack
social support or primary care (Joynt & Jha, 2013).
One factor mentioned with the concern for HRRP is that hospitals want to avoid

penalties so they are shifting care to outside resource settings to discharge quicker rather
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than providing high quality care (Shah et al., 2015). To avoid the ticking time clock

patients are held in the emergency department or they are admitted for observation (less
than 24 hours). There have been slight reductions in readmissions but less gains in

quality of care (Shah et al., 2015).
Shah et al., 2016 identified the factors in patients that have an increased risk of
30-day readmissions. Patient and hospital-level factors were identified, these included;

black race, comorbidities (congestive heart failure, frailty, chronic renal insufficiency,
diabetes, depression, anxiety, psychosis, alcohol and drug use), discharge to post-acute

care, dual eligibility for Medicare and Medicaid, elevated serum arterial blood carbon
dioxide level, low BMI, longer length of stay and male sex. Shah et al, 2016 stated in his

study that the use of post-discharge care and the quality of care that is given from these
agencies needs further investigation. There are not any algorithms that currently
integrate data into a predictive model that can stratify a patient for risk early enough in

the care process to find the appropriate care post discharge (Shah et al, 2016).

Problem Investigated
The problem investigated for this study was the 30-day readmissions of COPD
patients and what post-discharge care settings (HSC, HHC, SNF and LTAC) illustrating
the common covariates of COPD patients that are readmitted at the Small Urban

Community Hospital. Each post-discharge care pathway was evaluated to determine if
the selected care was associated with incidence of 30-day readmissions.
Improvement in the Management of COPD at SUCH

The overall aim of this project is to find out if there is a significant difference in
30-day readmission rates for the post-discharge care settings, and from this data suggest
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how to make improvements in how COPD is managed at Small Urban Community
Hospital.

Managing COPD aims to enhance the quality of life, and maintain or improve
functional status through inpatient and outpatient rehabilitation services, addressing

comorbidities, and minimizing or managing exacerbations and other characteristics of
COPD (Foster et al.,2007). As of right now, there are different protocols for managing
COPD at SUCH.

There were two primary objectives for this study. The first focused on the

examination of each post-discharge care pathway chosen and which patients readmitted
and its relationship to 30-day readmission frequency.
The second objective of this study focused on the characteristics of each patient
that readmitted within 30-days individually and by discharge group. Each patient’s

medical chart was examined for demographics, respiratory symptoms, risk variables,

comorbidities, diagnostic groups, hospital testing and medications and all physician
documentation and patient history for the clinical practice management of each patient
diagnosed with COPD. When reviewing the patient medical charts each patient was
scored by variable according to severity by the listed numerical documentation. With an
early identification of significant variables from this study a systems process can create
an awareness with alerts to case management that patients with certain characteristics can

be at risk of 30-day readmission at the Small Urban Community Hospital (SUCH) with
COPD.

The identification of variables to predict readmission and the determined pathway

of care will promote the adherence to a program to increase the most significant
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improvement in the patient’s COPD, improve quality and practice and decrease the

financial expenditures for readmissions (Simons-Morton, McLeroy & Wendel, 2012).
Hypotheses/ Research Questions

RQ1: Is there a significant difference in 30-day readmission rates for the post
discharge care settings (discharge to home with self-care, home with home health

care, skilled nursing facility, and long-term care facility) in patients with COPD?
Ha1: There will be significant differences in patients who get discharged to

different post-discharge care settings (HSC, HHC, SNF and LTAC) who get

readmitted within 30 days after index admission with COPD versus those who do
not get readmitted back to the hospital within 30 days of their indexed admission

with COPD.

RQ2: Is there a significant difference in patient characteristics (covariates)
between those patients that get readmitted and those patients that do not get

readmitted?
Ha2: There will be significant differences in the characteristics (covariates) of
patients who get readmitted back to the hospital within 30 days of their indexed

admission and those that do not get readmitted with COPD.
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CHAPTER II

LITERATURE REVIEW
COPD is currently the fourth leading cause of death in the United States, as

documented for the Center of Disease Control (Centers for Disease Control and
Prevention, 2018). Even though COPD is a largely preventable, slightly reversible

disease, COPD’s global and national burden remains high (Pauwels et al. 2001). It is

projected that COPD will exceed $49 billion in medical costs by the year 2020 (Global
Initiative for Chronic Obstructive Lung Disease, 2019). Exacerbations of COPD account
for up to 75% of the total disease cost. An estimated 29 million Americans aged 20 - 79
are living with COPD (National Institute of Health, 2018). COPD has led to more than

800,000 hospitalizations a year (Centers for Medicare and Medicaid Services, 2019). In
the future, COPD is expected to increase globally because of the risk factors for COPD
and the aging of the population (Mathers & Loncar, 2006). Hospital readmissions caused
by an acute exacerbation of COPD is very common worldwide (U.S National Heart,

Lung and Blood Institute [NHLBI], 2001; Mannino, 2003; Lau, Yam & Poon, 2001).
This chapter will be divided into many categorical areas to describe the small
urban community hospital, the patient population, COPD as a disease and the
components to manage COPD patients. Although exhaustive, the literature review was
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deemed necessary to understand the disease in its entirety and to use the information to
develop the covariate scoring chart which was used to help identify the biggest factors
that influence 30-day readmissions within each post-discharge category. This study will

be used to improve the discharge process and educate the healthcare system of the factors
that may influence the risk of 30-day readmissions relative to the SUCH population.

Small Urban Community Hospital

It is important to describe the setting where this study took place. The small
urban community hospital was founded in 1865 in Cleveland, Ohio. Small urban

community hospital is Cleveland’s oldest private hospital/medical center. SUCH has an
available 205-bed capacity and has 6000 admissions per year. SUCH is considered a

short-term acute care facility run as a nonprofit organization. The hospital has Joint
Commission accreditation (Small Urban Community Hospital, 2019). The clinical

services provided include cardiovascular, emergency, oncology, orthopedic, radiology,

nuclear medicine and imaging, rehabilitation, special care, psychiatric, surgical, and
wound care (Small Urban Community Hospital, 2019). The highest inpatient utilization

categories are psychiatry, orthopedic surgery, internal medicine, cardiovascular services,

and pulmonology. The highest categories for outpatient services include imaging, clinic
visits and related services, ED visits, and nerve injections (Small Urban Community
Hospital, 2019). The hospital has nearly 400 physicians on the Medical Staff. Most of the

physicians are independent, and the medical group housed at SUCH employs 35
physicians. SUCH has a medical residency program which gives medical students a

chance to work with an urban population. The residency program at SUCH consists of 57
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residents from many different states and countries (Small Urban Community Hospital,
2019).

Patient Population Served

The hospital commits to the community it serves. The healthcare workers and
staff have an understanding of the type of health needs and the social and environmental

determinants of health in the community such as access to healthy food, safe and
affordable housing, financial resources (Ohio Department of Health, 2018). These
community resources are not evenly distributed throughout the city and can have a

significant impact on health outcomes of the patient population (NACCHO, 2018). A
Community Health Needs Assessment (CHNA) was completed in 2015 and 2018 to

identify the most significant health needs within the community and the specific
population's characteristics (Cuyahoga County Community Health Needs Assessment
2016) (Cuyahoga County Community Health Needs Assessment, 2019). The assessment

recognizes that health is multi-factorial and those across the city especially with the
people of color are excessively burdened with poor health and higher rates of chronic
disease (Cuyahoga County Community Health Needs Assessment 2016) (Cuyahoga

County Community Health Needs Assessment, 2019). The information helps to capture
the patient population and their dwelling in which the study was conducted.

The hospital market area population is 852,600; 74.3% of the patient discharges
are citizens of the primary market area (Cuyahoga County Board of Health, 2019). The

primary market area, which is called the Central Neighborhood in the hospital's

surrounding area, consists of 93.9% of the patients. In the primary market area, 69.7 % of
patient discharges were Medicaid patients, and 4.5% were Medicare patients (Cuyahoga
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County Board of Health, 2019). Twenty-one percent do not have insurance, and 4.3%
have private insurance. Cuyahoga county is 63.9% white, and almost 30% African

American. The population served by the hospital is nearly 96% African American. The
area's median household income is $9,418, with the majority on public assistance income

and food stamps (Cuyahoga County Board of Health, 2019). Poverty is a life-threatening
issue that impacts the Central Neighborhood residents. The unemployment rate is above

12% in this area and many residents in the area surrounding the hospital may not have
obtained a high school degree, especially with those 65 years of age and older, female
and black (Cuyahoga County Board of Health, 2019). Ninety percent of the families

have a female head of the household, no husband present with children under five years,
and live under the poverty line. The population is primarily aged 25 to 34 and 55 to 64

(Ohio Department of Health, 2018).

A wide range of health conditions and challenges in access to care exists across
the community. The issue of generational poverty has been experienced by many. There

is a lack of available jobs, and many residents with past felony convictions cannot find
employment, which creates barriers to the neighborhood’s economic stability. There is a

lack of stable, affordable housing that also impacts the residents’ ability to have a stable

home environment, leading to the development of chronic health conditions.

Several factors hinder the residents’ ability to make healthy choices, including
insufficient availability of low-cost healthy foods, lack of supermarkets, and a lack of
awareness about what foods make up a healthy diet.

Many community residents suffer from chronic stress stemming from poverty,
illegal activity in the neighborhood, and other stressors that impact many resident' lives in
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the Central Neighborhood. It is understood that many of the patients cannot be compliant

with treatment protocols given their life circumstances: alcohol and drug abuse run

rampant in the neighborhood. A vast majority (68.2%) of the patients may have some
chronic mental illness such as schizophrenia/affective disorder, depression/mood
disorders, or bipolar disorders (Cuyahoga County Community Health Needs Assessment
2016) (Cuyahoga County Community Health Needs Assessment, 2019).

Because of the low level of health literacy within the patient population,
education is rarely provided on managing the various chronic diseases that are diagnosed.
Patients lack financial security, which creates a disincentive for residents in the
community to seek appropriate healthcare services until they reach a crisis. They go to
the emergency room instead of a primary care provider. The most common ambulatory

care sensitive conditions (ACS) for Small Urban Community Hospital’s discharged
patients are congestive heart failure, cellulitis, chronic obstructive pulmonary disease
(COPD), and diabetes. Almost 60% of discharged patients have hypertension (Small
Urban Community Hospital, 2019).

Frameworks for the Study
The health belief model (HBM) was employed to create the theoretical basis for
this research study. The HBM is a model frequently used in social psychology to
evaluate health behavior and is commonly used in advocating behavioral change

(Simons-Morton, McLeroy & Wendel, 2012). The HBM has been particularly useful in
the management of various chronic conditions. The health belief model’s premise is that

beliefs about susceptibility and severity of a disease or health concern and the thoughts

about the usefulness of preventative action or management of a disease or illness can
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predict the likelihood of an action. Initially, the theory was used to identify screening

determinants of chronic diseases and participation in programs to detect and prevent
illness (Simons-Morton, McLeroy & Wendel, 2012).

The Andersen healthcare utilization model was used for the systematic
identification of the covariates and the development of the covariate scoring sheet. The
model was also used to evaluate patient characteristics and other predisposing or enabling
factors (Andersen, 1995). The Donabedian model was also used to provide a context in

which health care services could be evaluated focusing on structure, process, and
outcomes (Donabedian, 1988).

Definitions/Classifications of Chronic Obstructive Pulmonary Disease

American Thoracic Society/European Respiratory Society (ATS/ERS) - “Chronic

obstructive pulmonary disease (COPD) is a preventable and treatable disease state,
characterized by airflow limitation that is not fully reversible. The airflow limitation is
usually progressive and is associated with the abnormal inflammatory response of the

lungs to noxious particles or gases, primarily by cigarette smoking. Although COPD

affects the lungs, it also produces systemic consequences” (Burge & Wedzicha, 2003).
Canadian Thoracic Society - “Chronic obstructive pulmonary disease (COPD) is

a respiratory disorder largely caused by smoking and is characterized by progressive,
partially reversible airway obstruction and lung hyperinflation, systemic manifestations
and increasing frequency and severity of exacerbations” (Burge & Wedzicha, 2003).
Global Initiative for Chronic Obstructive Lung Disease (GOLD) - “COPD is a

preventable and treatable disease with some significant extra-pulmonary effects that may

contribute to the severity in individual patients. Its pulmonary component is
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characterized by airflow limitation that is not fully reversible. The airflow limitation is
usually progressive and associated with abnormal inflammatory response of the lung to

noxious particles or gases” (Burge & Wedzicha, 2003).
National Institute for Health and Clinical Excellence - “COPD is characterized
by airflow obstruction. The airflow obstruction is usually progressive, not fully

reversible, and does not change markedly over several months. The disease is
predominantly caused by smoking” (Burge & Wedzicha, 2003).

World Health Organization (WHO) - “(COPD) is a lung disease characterized by
chronic obstruction of lung airflow that interferes with normal breathing and is not fully

reversible” (Burge & Wedzicha, 2003).
Although there are five definitions listed, all five have commonalities.

Predominant symptoms include chronic cough, production of sputum, and shortness of
breath with exertion. Patients can have reduced lung function, which in turn, reduces

quality of life. With the decrease in lung function, exercise tolerance and their quality of
life diminish. With the related symptoms, a downward spiral occurs, and the frequency

of exacerbations increases along with hospitalizations and pharmacologic treatment
(Fromer, 2011). Unfortunately, because of COPD being a prevalent condition, half of the
24 million adults in the United States who have COPD are misdiagnosed as asthma or

emphysema or completely undiagnosed (Wise & Tashkin, 2007).
Introduction to COPD
COPD has been an umbrella term used for two different conditions: chronic

bronchitis which is clinically diagnosed, and emphysema done radiographically or
through pathologic diagnosis (Christie, 1944). With chronic bronchitis, airway resistance
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is caused by inflammation and mucus production and does not affect airflow obstruction.
With emphysema, there is damage to the alveolar septa, which reduces the gas exchange

and reduces the elastic recoil after the lungs are inflated, which causes air trapping and

hyperinflation. Because shortness of breath is the main characteristic of COPD (Christie,

1944), individuals may have anxiety and fear because of their perception of

breathlessness. They may not know when to seek medical attention, abandon activity and
go to the doctors. Some patients may have a cough and sputum productions, some

coughs may produce mucous, and some may have a dry cough (Global Initiative for
Chronic Obstructive Lung Disease, 2019).

With COPD, the limited airflow usually advances and is associated with the
lungs’ uncharacteristic inflammatory response to harmful particles or gases because of

the airway and/or alveolar abnormalities (Overington et al.,2014). The most common
respiratory symptoms include dyspnea (shortness of breath), cough and/or sputum

(mucus) production, chest tightness and wheezing, and congestion of the bronchi

(Overington et al., 2014).
COPD’s main characteristic is a persistent inflammation of the lungs that disturbs

the central airway, alveoli, lung parenchyma, and any pulmonary vasculature. The main

mechanisms that promote these changes are the remodeling and narrowing of the airway

(Global Initiative for Chronic Obstructive Lung Disease, 2019). The increase in the
number of goblet cells and the swelling of mucus-secreting glands of the central airways
can change the vascular bed, which leads to pulmonary hypertension. These are the

pathologic changes that define the clinical presentation (Global Initiative for Chronic

Obstructive Lung Disease, 2019).
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Background/History of COPD

Some researchers describing conditions as we know as COPD today were Swiss
Physician Theophile Bonet, 1679, who referred to a condition as “voluminous lungs”,

and the term “turgid” lungs was referred to by Italian anatomist Giovanni Morgagni in

1769 (Petty, 2006). In the year 1814, the British physician recognized chronic bronchitis
as part of COPD. He used the term “catarrh” to explain constant cough symptoms and
excessive amounts of mucus that COPD can produce (Petty, 2006). The clinician,

pathologist, and inventor of the stethoscope Renee Laennec wrote the first descriptions of

bronchiectasis, pleurisy, pneumonia, and other lung diseases in 1821. He especially
recognized the lungs’ hyperinflation that did not empty well and designated this condition

as emphysema (Petty, 2006). In 1846, John Hutchinson invented the spirometer, which is

used as an essential tool in diagnosing COPD. Today, the spirometer is not used to its

maximum potential for diagnosis and management of COPD (Petty, 2006). Tiffeneau
added the idea of using the timed vital capacity to measure airflow to become an

instrument for diagnosis. Gaensler perfected the concept of using air velocity index for

diagnosing COPD based on Tiffeneau’s previous work. They both helped with the
development of FEV1 and FEV1/FVC ratios, is currently used to determine the severity of
disease (Petty, 2006).
Ronald Christie recommended that “the diagnosis of emphysema should be

considered when there is dyspnea on exertion of cumulative onset not because of
bronchospasm or left ventricular heart failure which can appear in a patient that has some

physical signs of emphysema together with chronic bronchitis and asthma” (Christie,
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1944). Christie identified COPD’s components by relying on the history and physical

examination for the diagnosis of each patient (Petty, 2006).
The CIBA Guest symposium in 1959 and The American Thoracic Society (ATS)

Committee in 1962 defined the constituents of COPD. The ATS defined the differences

in respiratory diseases; some did not use physiologic criteria (Ciba Guest Symposium,
1959). Chronic bronchitis is having a cough that lasts for a minimum of 3 months

continuously over 2 years. Emphysema has been defined by anatomic terms with
alveolar spaces that are enlarged with loss of alveolar walls. Asthma, on the other hand,

was described as having hyperresponsiveness to a variety of stimuli (Ciba Guest
Symposium, 1959). The literature recognized that bronchial hyperactivity and chest
infections plus exposure to irritants could identify the pathogenesis of COPD (Petty,

2006).
In 1976, Charles Fletcher identified that smoking could accelerate the level of

decline in the FEV1 which caused disabling symptoms (Fletcher et al., 1976). It was

determined that if an individual would quit smoking, this could slow the degree of FEV1
decline. This information started developing smoking cessation at each stage of the

disease (Fletcher et al. 1976).

By the time a patient presents clinical signs, they are frequently in a moderate to

severe stage of COPD (Fletcher et al., 1976). It was also found that COPD often begins
with overly complex small airway changes and cellular events surrounding the alveoli,
leading to the decline in elastic recoil in which the lungs start to expand and the forced
vital capacity increases (Petty, 2006).
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COPD starts with the loss of elastic recoil, inflammation, increase in mucous

production, bronchospasm, and the FEV1 will decrease; this can also be the early stages

of emphysema (Petty, 2006). Many advances have been made with COPD in the past;
this summary of the history was meant to explain how COPD’s identification got started

with a brief overview of the tools to measure and identify the disease.

Overview of COPD
Prior to the 1960’s, COPD was not a common disease because lifespan was

shorter, and testing was not as prevalent. Six times as many men die versus women from
COPD (Mannino, 2006). A person was more likely to be diagnosed with chronic

bronchitis or emphysema than COPD. COPD was not used as a common diagnosis. The
spirometer was only available in specialized settings to measure the volume and rate of
flow of breath that is used to diagnose COPD today. In the past, smoking was not known
as a risk factor for lung diseases or presented addictive properties (Mannino et al., 2003).

There were not many therapies available to help individuals quit smoking. Doctors were
very unsure of the treatments available as well as the efficacy to alleviate symptoms of

COPD. Primarily, the research focused on proteases and the enzymes released by

inflammation in the lungs that were suspicious in individuals that had emphysema and
that cause the destruction of the lungs (National Institute of Health, 2018).
More than 16 million people today have COPD; it has become quite common.

Approximately 120,000 people die from it each year. Additionally, more than 12 million

people are thought to have COPD that has not been diagnosed (National Heart, Lung and

Blood Institute, 2020). Deaths of women that have the disease are on the rise. Today,
spirometry is widely available to doctors in both the office and hospital setting to confirm
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the COPD diagnosis but is still underutilized (Kenealy et al.,2011). Today recognition of
cigarette smoking and nicotine addiction allows doctors to provide referrals to smoking

cessation programs and other counseling to overcome nicotine addiction (Pauwels et

al.,2019). Treatments are now available to vaccinate against influenza and pneumonia,

which can lead to COPD. Bronchodilator drugs, and glucocorticoids and/or antibiotics or
both are used to treat an exacerbation of COPD (Silver et al., 2017). Other
recommendations are made to participate in pulmonary rehabilitation, use oxygen therapy

and investigate surgical interventions (Casey et al., 2013). Research has prevailed in

nocturnal oxygen therapy and lung volume reduction surgery to improve the COPD
patient’s quality and longevity of life. Research continues on COPD and the

inflammatory and immune components to COPD. The National Institute of Health (NIH)

has partnered with advocacy groups to promote COPD education and awareness
(National Institute of Health, 2018).

It has been documented that 10-20 % of patients who have COPD never smoked a
cigarette, implying that both genetic and environmental factors can influence the

development of COPD (National Institute of Health, 2018). A study is presently being

conducted by the National Institute of Health is recruiting 10,000 smokers and non
smokers to identify the genetic factors that determine why some people develop COPD
and others do not. Studies are currently being designed to use genomic information to
analyze phenotypes and biomarkers to determine how COPD affects different
subpopulations. Other studies will be done on therapeutic trials with the effectiveness of
two different pneumococcal vaccines in those patients diagnosed with COPD.

Azithromycin is being tested on COPD patients to evaluate whether it reduces the
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number and severity of exacerbations. Lung tissue research will continue to explore the

basis of COPD and other lung diseases. Continued investigation will improve the
understanding of disease treatment and management through research and early

interventions (National Institute of Health, 2018).
Development of New Issues

There is a significant need to develop improved treatments for COPD (Healthy
People, 2020). Currently, there are no drug therapies that reduce the progression of the
disease (Montuschi, 2006). There have been many developments in the advancement of

asthma because of a better understanding of the underlying disease (Barnes, 2018). Liu et
al., 2018 evaluated the use of inhaled steroids, increasing the prevalence of developing
repetitive bacterial infections. It was found that inhaled steroids depress the immune
system and increase the risk of developing respiratory infections, including

nontuberculous mycobacterial (NTM) lung infections (Liu et al., 2018). NTM infections
are exceedingly difficult to treat and can even cause death. The medical records of 549

patients were analyzed over ten years. It was found that the higher the inhaled steroid
dose as well as how long the patient was on the steroid, the higher the chance was of

developing NTM lung infections. As many as 75% of COPD patients may be taking an
inhaled steroid. According to the authors, only a very modest number of patients benefit
clinically from this treatment (Liu et al., 2018).

Pasquale et al. 2019, investigated the consequences of community-acquired
pneumonia (CAP) in any patient that has COPD. The CAP Burden of Illness

Questionnaire (CAP-BIQ) was distributed to 490 participants. A total of 481 completed
the survey. More than 90% had symptoms for two weeks to a month following the
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diagnosis. Symptoms included fatigue, headaches, trouble sleeping, and confusion.

Patients were absent from work for an average of 21 days and could not perform usual

activities of daily living. Information was collected directly from the patients. Self
reporting the prevalence of symptoms may not have been the most reliable method of

collecting the information on these patients. Timing, recall, and description of symptoms
may not have been accurate due to factors related to health literacy (Pasquale et al.,
2019).

Mild and moderate small airway disease was investigated using novel

multiresolution CT imaging on tissue samples of the whole lung or lobes of smokers with
normal lung function (Hyun-Kyoung Koo et al., 2018). All 4 GOLD lung classification
stages were used for the study. Out of the 34 patients, 10 were controls (smokers with

normal lung function). The results indicated that “the number of terminal bronchioles

decreased by 40% in GOLD 1 COPD and 43% in GOLD 2 COPD. The number of
transitional bronchioles decreased by 56% in GOLD 1 and 59% in patients with GOLD 2.

The alveolar surface area decreased by 33% in GOLD 1 and 45% in GOLD 2 patients”

(Hyun-Kyoung Koo et al., 2018). These pathological changes correlated with decreased
lung function. The study showed that in COPD patients with mild to moderate COPD
can be a pathological feature. The need for stage classification is necessary for the early
diagnosis of the disease because a patient may present with only intermittent symptoms.

Early interventions may prevent rapid escalation to GOLD 3 or 4 (Hyun-Kyoung Koo et

al., 2018).
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Level of Evidence of COPD Cases
Lozano et al. 2012, did an analysis systematically on the burden of COPD in

2010. The study evaluated all available data in 187 countries and 235 causes of death
from 1980 to 2010. Data were analyzed using extensive record review. The Cause of

Death Ensemble model (CODEm) approach was used in every age and sex group. Some

of the leading causes of death in 2010 were COPD, lower respiratory infections, lung

cancer, ischemic heart disease, stroke, and HIV/AIDS. In 1990, the ascending order of
rank of COPD was number 4 with the potential of COPD to move to number 3 by 2020,
with Ischemic heart disease found as number 1 and stroke at number 2. Falling behind
COPD was lower respiratory infections and lung cancer. With the identification of

cause-specific mortality, the number of people who die according to what age and from
what disease is essential in prioritizing research to develop policy, interventions, and new

health technologies (Lozano et al., 2012).
Ford et al., 2013, completed the COPD surveillance report for the United States in
2011. The national data systems provided data on adults aged 25 years or greater.

Almost 13.7 million had been documented as having a diagnosis of COPD. During the
previous year, only 10.3 million were diagnosed in a physician’s office, 1.5 million had
visited the emergency department and, 700,000 were discharged with a diagnosis of
COPD. It was noted that the trends of patients diagnosed were younger and that the
death rates increased in adults from the age of 45 to 54 years and among American Indian

and Alaskan natives. COPD declined in those aged 65 to 74 years of age and among

Hispanics and Asian/Pacific Islanders. This study suggested that there has not been
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progression in preventing COPD in the United States in specific populations (Ford et al.,

2013).

Burden of COPD
The Global Burden of Disease Study reports having 251 million cases of COPD
throughout the nation in 2016. More than 90% of COPD deaths occur in low-and

middle-income countries (Lozano et al., 2012). According to the Centers for Disease

Control (CDC), an estimated 15 million people in the United States have been told that
they have COPD in 2015 (CDC, 2018). According to the Behavioral Risk Factor
Surveillance System (BRFSS) survey completed in Ohio in 2011, 9.2% of the residents
reported having the disease. The primary cause of COPD is being exposed to tobacco

smoke either actively or through secondhand inhalation (CDC, 2018). Other

determinants include being exposed to air pollution, either indoor or outdoor, and dust
and fumes from occupational hazards. Some cases are due to long-term asthma. States
with the highest COPD death rates come together along the Ohio and Mississippi Rivers.

Other statistics reported from those having COPD were that they were on disability, did
not graduate from high school, had an income with all household members less than

$25,000, were divorced, widowed, or separated, were a smoker or had a history of asthma
or other respiratory diseases (Ford, Croft, Mannino, Wheaton, & Giles, 2013).
Factors that Influence Disease Development and Progression

The most significant risk factor for COPD is for those who smoke tobacco

(American Lung Association, 2020). Other environmental toxins such as biomass fuel
exposure or air pollution can contribute to the disease (Fullerton, Bruce & Gordon

(2008). Besides the previously mentioned factors, other factors may predispose an
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individual to develop COPD. These include genetic defects, malformed lung
development, and accelerated aging (Tsui et al, 2016). Other risk factors include

previous hospital admissions, hypercapnia, and patients on oxygen long-term.
Depression and anxiety have also been shown to be related to a higher risk of
readmission (Bahadori & FitzGerald, 2007).

Other factors that influence disease development and progression are awareness
and knowledge about COPD with primary care practitioners (PCP’s) (Bhatia & Fromer,

2011). Health care providers may not clinically diagnose COPD or delay the diagnosis
which, may only be recognized in its later stages, and the patient may have worsening

symptoms and a poor quality of life with a rapidly declining condition. Guidelines have

been developed to help clinicians recognize patients with symptoms and help in the early
stages of COPD diagnosis. (Bhatia & Fromer, 2011).

Not using the proper diagnostic tools cause an underdiagnosis or misdiagnosis of
COPD (Foster et al. 2007). Spirometry is an essential tool diagnosing COPD, and it is

commonly not used even when available. A survey of 943 PCP’s found that only 64% of
established physician practices had access to spirometry, 34% of the physicians

extensively used the instrument for COPD diagnosis (Foster et al., 2007). Diagnosis of
COPD can also be confused by diagnostic criteria between COPD and asthma. When
patients have a cough, dyspnea, and limited exercise tolerance, physicians have a

partiality towards asthma especially in women (Chapman, Tashkin & Pye, 2001).
Tinkleman, Price, Nordyke, and Walsh, 2006 studied 597 patients and found the

misdiagnosis of COPD and asthma quite common. Forty percent of those previously

diagnosed with asthma had COPD. Factors that influence profitability may influence
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asthma bias because of having the performance pay incentive (Tinkleman et al., 2006).
There has not been an incentive to promote and improve COPD diagnosis and

management. (Griffiths et al., 1999).
Symptoms of COPD

The most common symptoms of COPD are dyspnea (shortness of breath). Cough

with sputum (mucus) production and presents in approximately 30% of all patients

(Bhatia & Fromer, 2011). COPD symptoms may change each day and change with
progression over time. The limited airflow diminishes over time. Those patients that

present with the above-listed symptoms should be thoroughly examined for the potential
cause of these symptoms. Physicians may base the diagnosis on the listed symptoms in
Table 2.1 and on the functional status of the patient. Patients may go to the hospital or
visit their physician because of long-term respiratory symptoms or because they have an

exacerbation of respiratory symptoms (Global Initiative for Chronic Obstructive Lung

Disease 2019).
Other causes of chronic cough [intrathoracic] include lung cancer, tuberculosis,

asthma, interstitial lung disease, left heart failure, and cystic fibrosis. Additional causes
of chronic cough [extra thoracic] include effects from medication including, ACE
inhibitors, postnasal drip syndrome, chronic allergic rhinitis, upper airway cough

syndrome, and gastroesophageal reflux (Global Initiative for Chronic Obstructive Lung

Disease 2019).
Other symptoms include wheezing and chest tightness. A wheeze heard through a
stethoscope may happen at the laryngeal level. Wheezes heard both inspiratory and

expiratory may be heard on auscultation. Chest tightness presents itself with exertion or
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exercise that may be muscular and will happen because of the intercostal muscles’

contraction. If a patient does not have wheezing or chest tightness, this does not exclude
COPD or asthma (Global Initiative for Chronic Obstructive Lung Disease 2019).

Other factors associated with COPD include fatigue and weight loss. Weight loss
is common in patients with Level IV or very severe COPD (Hanania et al., 2011). Other
diseases such as tuberculosis or lung cancer should be considered, and all symptoms

should be investigated. Syncope during cough can occur because of the quick increase in
intrathoracic pressure during long coughing attacks (Hanania et al., 2011). Coughing

may cause rib fractures. Ankle swelling may be the only indication of cor pulmonale
(enlargement of the heart’s right side). Because of the reduced quality of life, patients

may have the onset of depression or anxiety (Hanania et al., 2011).

Diagnosis and Assessment
A COPD diagnosis should be based on several factors including, dyspnea, cough
or mucus production, a frequent history of lower respiratory tract infections and an
awareness of exposure to risk factors such as tobacco, indoor/outdoor pollution, and

occupational hazards (Global Initiative for Chronic Obstructive Lung Disease, 2019).
The key indicators are listed in Table 2.1. The use of spirometry or a PFT is essential to
making a clinical diagnosis. The existence of a post-bronchodilator Forced Expiratory

Volume of Air in one second (FEV1) < 0.70 can verify the presence of limited airflow
along with the patient’s identification of symptoms and noted exposure to harmful toxins

of a COPD patient (Global Initiative for Chronic Obstructive Lung Disease, 2019).
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Table 2.1 Indicators for considering a diagnosis of COPD

Description
“Progressive over time
Characteristically worse with exercise
Persistent
Chronic Cough:
May be intermittent and may be
unproductive
Recurrent wheeze
Chronic Sputum Production:
Any pattern of chronic sputum production
Lower Respiratory Tract Infections
Recurrent
History of Risk Factors:
Host factors (such as genetic, congenital,
developmental)
Tobacco smoke (including popular local
preparations)
Smoke from home cooking and heating
fuels
Occupational dust, vapors, fumes, gases,
and chemicals
Family History of COPD and
For example, low birth weight, childhood
respiratory examples”
Childhood factors
(Global Initiative for Chronic Obstructive Lung Disease, 2019)
Symptom
Dyspnea that is:

“Spirometry is the most accurate and factual measurement of airflow limitation.

Spirometry should measure the volume of air forcibly exhaled from the point of maximal
inspiration (forced vital capacity, FVC), the volume of air exhaled in the first second of
the test (forced expiratory volume in one second, FEV1), and the ratio between the forced
vital capacity and forced expiratory volume FEV1/FVC ratio. The presence of a post

bronchodilator FEV1/FEV < 0.70 confirms the presence of persistent airflow limitation

and determines if a patient has COPD. Spirometry should always be compared to the
reference values based on age, height, race, and sex” (Pellegrino et al., 2005). The

GOLD Classification of Airflow Limitation Severity in COPD (based on post
bronchodilator FEVi). GOLD 1: mild - FEVi > 80% predicted, GOLD 2: moderate -

50% < FEVi < 80% predicted, GOLD 3: Severe - 30% FEVi < 50% predicted, GOLD 4:

Very Severe - FEV1 < 30% predicted (GOLD, 2020).
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A medical assessment of a new patient who may have symptoms or is suspected

of having COPD should include patient exposure to risk factors such as smoking and any
environmental exposures (Stephens & Yew, 2008). Identifying a patient’s past medical

history including, allergies, asthma, nasal polyps’ sinusitis, any repetitive respiratory
infections as a young child, and any other respiratory or non-respiratory diseases
(Stephens & Yew, 2008). Family history of COPD or respiratory diseases can be

important in the evaluation.
Evaluating the patient’s symptom development, such as increased shortness of
breath, more winter colds, and the number of years the patient did not seek out medical

treatment and noting the history of hospitalizations for respiratory problems and

worsening episodes not seeking medical help (Stephens & Yew, 2008). Evaluation of

comorbidities including heart disease, musculoskeletal disorders, osteoporosis, and any
malignancies that may cause a restriction of the airway and limited activity (Stephens &
Yew, 2008). Other physiological factors that need evaluation to determine respiratory

distress include oxygen saturation (SaO2), measurement of oxygen in the blood (PaO2)

and the level of carbon dioxide in the bloodstream as COPD worsens and these results
will determine the mechanisms involved with each patient (Global Initiative for Chronic

Obstructive Lung Disease 2019; Cukic, 2014). Physicians will evaluate how the disease
impacts a person’s life such as avoiding activity, missing work, having an economic

impact, performing activities of daily living, depression, and anxiety. Evaluating a
patient’s social support or living situation and how to reduce risk factors is also essential

(Stephens & Yew, 2008).
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Management of COPD

Treatment regimens are very individualized with a patient who has COPD
(Montuschi, 2006). In previous years smoking cessation has been the most effective

intervention for slowing COPD progression (Bantus, 2013). Global Initiative for Chronic

Obstructive Lung Disease, 2019 stated that by initiating early pharmacological therapy at
the early stages of COPD can reduce symptoms, reduce the number and severity of
exacerbations, and improve the ability to exercise and complete activities of daily living.

Inhalers remain the initial choice of optimal medical management. The choice of
medications depends on the cost and availability and the insurance provider’s coverage.

Each treatment regimen is based on the severity of the patient’s symptoms, airflow
limitation, and exacerbation history (Global Initiative for Chronic Obstructive Lung

Disease, 2019).

Spruit et al., 2013 reviewed pulmonary rehabilitation as a multidisciplinary
intervention based on patient assessment followed by an individualized treatment plan
that includes exercise training, education, medication management and self-management

of symptoms aiming at behavior change designed to improve COPD’s physical and
psychological conditions. Pulmonary rehabilitation is the most effective strategy that
improves shortness of breath, health status and exercise ability (Spruit et al., 2013). It

was stated that symptom control and palliative care can help patients with symptoms as
well as the management of the disease (Spruit et al., 2013).

COPD is highly unpredictable and has many elements that can affect a person,
such as fatigue, dyspnea, insomnia, depression, and anxiety, requiring symptom-based

palliative treatments (Seamark, Seamark & Halpin, 2007). The long-term administration
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of oxygen therapy with chronic respiratory failure improves outcomes and management
in patients with stable COPD (Kim, Benditt, Wise, & Sharafkhaneh, 2008; Stroller,
Panos, Drachman, Doherty, & Make, 2010).
Guidelines have been developed by ATS/ERS, GOLD, NICE, and CTS to

diagnose and treat COPD. The GOLD guidelines provide a simple classification for

patients’ education and treatment. These guidelines are very comprehensive and help to

confirm an early diagnosis and improve the management of COPD (Global Initiative for
Chronic Obstructive Lung Disease, 2019). It is recommended that patients over 40 years

of age, that have activity limitations, shortness of breath, and a cough with a history of
smoking should get a COPD evaluation, especially when they have a history of smoking

or exposure to occupational or environmental hazards (Global Initiative for Chronic

Obstructive Lung Disease, 2019). Additionally, patient spirometry should be an essential
part of a respiratory practice or pulmonology as electrocardiography is to a

cardiovascular investigation or cardiologist in determining appropriate diagnosis

(Mannino, Ford & Redd, 2003).

Challenges with the Management of COPD
The literature identifies that 10 to 55% of readmissions for an acute exacerbation

of COPD may be prevented (Benbassat & Taragin, 2000) Some factors identified may
be discharging a patient prematurely because of the incorrect index admission, poor
medication compliance, lack of patient and family education regarding COPD, and lack

of follow-up with primary care physician and outpatient rehabilitation program referrals
(Benbassat & Taragin, 2000).
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There is low utilization of spirometry to confirm a COPD diagnosis (Spero et al.,

2017). There is sometimes a lack of understanding with the definition of COPD and the
fact that treatment may improve breathing, but it is not reversible when using a
bronchodilator (Spero et al., 2017). Clinicians may have difficulty performing

spirometry in a hospital setting and would rather see that patient be referred to an
outpatient setting to have a pulmonary function test performed by a respiratory therapist
(Griffiths et al., 1999). Patients who perform a spirometry test during their hospital stay

can produce acceptable results (Spero et al., 2017). Other factors that determine whether

a clinician will perform the spirometry test include the clinician belief that the patient
must have had spirometry to confirm their diagnosis (Spero et al., 2017).
Of the patients admitted for a COPD exacerbation, 1 in 5 will be readmitted to the

hospital for symptoms related to their disease within 30 days (Shah, Press, Husingh-

Scheetz & White, 2016). Many hospitals in developed countries have implemented
policies to enhance care quality and reduce costs related to COPD. COPD is part of
Medicare’s Hospital Readmission Reduction Program (HRRP) which was implemented

in 2012 (Centers for Medicare & Medicaid Services, 2019. This program penalizes
hospitals for 30-day readmissions for hospitalized patients for an acute exacerbation of
COPD. At this point there are very few programs in hospitals to help in the reduction of

readmissions with COPD patients (Centers for Medicare & Medicaid Services, 2019).
Morgan, Zakeri and Quint, 2017 defined the relationship between COPD and

CVD. Cardiovascular diseases are the most important comorbidity when evaluating
COPD. CVD is associated with longer lengths of stay in the hospital, increased risk for
rehospitalization and for all-cause cardiovascular disease death (Morgan, Zakeri & Quint,
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2017. There may be a lack of recognition and undertreatment of comorbid coronary

artery disease in COPD patients depending on previous treatment or physicians’ visits.
Because of this, most patients with symptoms of sputum, cough, and dyspnea upon

exertion are treated for COPD. There is an unmet need to review CAD, or any heart
related diseases when it comes to COPD. Coronary artery disease (CAD) also called

coronary heart disease (CHD) or ischemic heart disease (IHD), or just simply heart
disease involves the reduction in blood flow to the heart because of atherosclerotic plaque
that has built up in the arteries (Morgan, Zakeri & Quint, 2018).

Ford and Mannino (2004) used the findings from the National Health and

Nutrition Examination Survey to determine incidence of diabetes in those that have
impaired pulmonary function. Different forms of lung disease were studied. The
findings indicated that in the early stage of diabetes there may be changes in lung
function. This may be a biomarker for the potential diagnosis of diabetes. With more

frequent doctors’ visits a patient may have more opportunity to diagnose diabetes. COPD
was associated with a moderate increase of the risk of diabetes (Ford & Mannino, 2004).
Smoking, physical inactivity, poor diet, and air pollution exposure are all risk
factors for both COPD and CAD. Smoking increases an inflammatory response in the

body which contributes to chronic inflammation which in turn can rupture atherosclerotic
plaque. COPD is a consequence of the inflammatory response to inhaling noxious

particles (smoking). This will lead to disruption in the lungs and repair mechanisms

which becomes systemic and destroys the lung parenchyma. The systemic inflammatory
response associated with COPD puts a patient at risk for CHD (Sin & Man, 2003).
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It was mentioned in Braman, 2015 that there is no guarantee that reducing the 30day readmission rates would benefit and not harm the overall patient’s health and
outcomes of the hospitals. CMS assumes that there is a high quality of care with

treatment based on established guidelines, education for patients and family, and that
there is coordination of care post-discharge (Centers for Disease Control and Prevention,
202). Some of the challenges include identifying the target population for COPD
readmission specific to an urban hospital’s characteristics while patients are hospitalized.

The national average of patients readmitted for acute exacerbation of COPD within 30
days is 22% (Centers for Disease Control and Prevention, 2021). Another difference

would include the use of the classification of the disease. Differences in the use of
electronic health records and the use of International Classification of Diseases, Ninth

Revision (ICD-9) or the use of the Tenth Revision (ICD-10), as well as differences in

coding after discharge may be a challenge for the hospital (National Center for Health
Statistics, 2019).

There will be differences between health care systems due to public vs. private,
and inner-city vs. rural vs. suburban. SUCH is characterized as a private inner-city
institution. The readmission policies are identified by the Centers of Medicare and

Medicaid Services. The intervention for readmissions prevention is to utilize the patient

navigator throughout the patient process (Centers for Disease Control and Prevention,
2021).

Shah, Press, Husingh-Scheetz & White, 2016 explained that Medicare has

provided incentives to reduce 30-day readmission and instills a 3% penalty for an
overabundance of readmissions. SUCH penalties may be disproportionately higher
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because of the rate of those treated with limited resources. With the increase in hospital
penalties, an acute exacerbation (AECOPD) may be coded as another condition, thus

increasing the prevalence of health disparities due to changing the initial diagnosis and
transferring or referring patients to another health care facility to prevent penalties and
delay the patient from having further readmissions.

Does the delay of readmission improve patient health? Literature states that

higher rates for readmission are associated with lower expiration rates with patients with
COPD. Higher readmission rates can be a protective factor (Shah, Press, Husingh-

Scheetz & White, 2016). Twenty-five percent of patients with an acute exacerbation of
COPD do not recover lung function by day 30, leaving readmission as an appropriate
remedy (Donaldson et al., 2015). With the lack of consistency in the definition of COPD

and the change from ICD-9 codes to ICD-10 codes, the inconsistencies impair efforts in
the development of guidelines and comparison of studies on COPD (National Center for

Health Statistics, 2019). Some readmissions may be related to COPD, while others may

be related to other respiratory causes. COPD may be well defined, but post-discharge

and inpatient care may be lacking because of the improper diagnosis of symptoms and

inaccurate classification (Shah, Press, Husingh-Scheetz & White, 2016).
Stein et al., 2012 evaluated the validity of ICD-9 codes and the clinical
modification diagnosis codes for identifying COPD patients hospitalized for

exacerbations. The assignment of primary and secondary ICD-9 discharge diagnosis

codes is specifically done for reimbursement. It may be influenced by the clinical
documentation in the medical record and by the relative rate of reimbursement by the
insurance company. This raises concerns about the validity of this data for the
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identification of patients with chronic conditions. The coding algorithm varies from
hospital to hospital (Stein et al., 2012).

The COPD-ARTIFACT (Administrative Data to Identify COPD or Heart Failure)

study was performed by Stein et al., 2012 to evaluate COPD’s acute exacerbation (AECOPD) and how it was medically coded. Hospitalizations were included with and

without AE-COPD (Stein et al., 2012). There were two physician reviewers. Medical
records were reviewed from two years prior. Patients were determined to have an acute
exacerbation of COPD if the following criteria were presented; physician diagnosis of

COPD, chronic bronchitis, or emphysema in the admission note have presence of cough
for several days, dyspnea or sputum production, not dependent on color on presentation

and hospitalization for one or more of any respiratory symptoms. Patients with COPD

may have other pulmonary or cardiac conditions (pneumonia or heart failure). The

validity of 4 different algorithms was tested. Of the 49,239 patients admitted during the
study, 8,790 met the AE-COPD criteria, and only 20.8% had documented spirometry.

The sensitivity and specificity of the algorithms evaluated were low, especially when

related to a primary diagnosis of COPD. This indicates that hospitals are significantly
underestimating the burden of hospitalizations for an acute exacerbation of COPD and
that the incorrect coding will lead to an underestimated comparison of DRG’s as well as

lack of provision of quality of care and improvement for those with COPD. A limitation

of the study was that there was no requirement or evidence of airflow obstruction based
on spirometry to establish a clinical diagnosis (Stein et al., 2012). The study confirmed
the use of ICD-9 codes to capture the picture of COPD patients who underestimate the
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disease’s burden and the importance of improved treatment and care initiatives to manage

the continuum of care for COPD patients (Stein et al., 2012).

Misdiagnosis
Misdiagnosis of COPD is common. Those who are misdiagnosed usually have
higher hospitalization rates than those clinically diagnosed using spirometry (Gershon et
al., 2013). The diagnosis is usually based on history and a physical exam. The primary
symptoms of cough, dyspnea and wheezing can contribute to a variety of diseases.

Spirometry testing can be used to confirm the disease but is rarely used, leading to the
numerous misdiagnoses of COPD (Spero et al., 2017).
In a study conducted by Spero et al., 2017, examined a total of 6,018 patients
were admitted to the hospital and diagnosed as having COPD. Of the patients admitted,
504 had a spirometry test performed. Of the patients admitted, 104 patients were found

to have restrictive lung disease, and 16 patients were considered normal. More than one-

third of patients admitted to the hospital with respiratory symptoms and many times were
diagnosed with COPD inaccurately. Other factors of presentation of COPD may be
smoking history, BMI, and associated comorbidities. A history and physical examination

cannot make an accurate clinical diagnosis of COPD. Spero et al., 2017 identified that
spirometry was not used during hospital admission because the physician may want to
wait until the patient is clinically stable and has some time to recover (Spero et al., 2017).

Kenealy et al., 2011 examined spirometry for patients in the hospital and one

month after admission with COPD’s acute exacerbation. The clinical diagnosis of COPD
is based on a patient’s clinical symptoms and spirometry results. Spirometry is required
to assess the severity of COPD in a patient, and determines treatment recommendations
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based on clinical guidelines. The Global Initiative for Chronic Obstructive Lung Disease
(GOLD) guidelines state “when the patient is clinically stable and free from respiratory

tract infection” a spirometry test should be performed (Global Initiative for Chronic
Obstructive Lung Disease, 2019). The study also mentioned that the patient misdiagnosis
was more likely to occur if non-smokers; had a high BMI, hypertension, coronary heart
disease, congestive heart failure, or sleep apnea (Spero et al., 2017).
A study done by Kenealy et al., 2011 studied 101 with AE-COPD at a primary

care center to compare spirometry measurements to that those performed during their
hospital stay. Patients were identified as having mild to moderate COPD. It was found
that patients that were tested post-discharge had little change in spirometry five days after

post-discharge and again at one month. The pre-bronchodilator measurements were
reported. There were no patients who moved more than one GOLD classification up or
down (Kenealy et al., 2011).

Feinberg et al., 2017 found that patients are typically treated with inhaled
corticosteroid (ICS) and a long-acting beta-agonist (LABA) especially, LABA/ICS
combination. Patients are treated with LABA/ICS combinations without undergoing a
pulmonary function test (PFT) or having an evaluation by a pulmonologist. General

Practitioner’s (GP’s) may sometimes prescribe drugs based on a patients’ symptoms,
clinical examination, and smoking history (20 packs/year) (Feinberg et al., 2017).

Spirometry may not be used to confirm the level of respiratory disease with a follow-up
appointment to a respiratory therapist. Without clinically diagnosing COPD it may be
difficult to align the appropriate treatment. The most popular LABA/ICS combinations
will cover any COPD stage or any bronchial asthma (Bhatia & Fromer, 2011). It can be
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difficult to manage the disease with a patients’ lack of awareness of characteristics of
COPD (Feinberg et al., 2017).

Underdiagnosis
COPD is often underdiagnosed leading to unnecessary sickness and death
throughout the world. The underdiagnosis is attributed to the early stages of the disease

and may not present with symptoms or with as much intensity as moderate to severe

cases. Approximately 95% of stage 1 - mild COPD and 80% in stage 2 - moderate
COPD remain undiagnosed (Sandelowsky et al., 2011). Many efforts to diagnose COPD
including, screening and questionnaires that are not completed due to time consumption

within the hospital/primary care practices/urgent care facilities. Methods and studies

need to be performed regarding the early detection of COPD (Sandelowsky et al., 2011).

Sandelowsky et al., 2011 measured the occurrence and severity of underdiagnosed
COPD patients in an urgent care setting with respiratory tract infections with smoking
history and no prior pulmonary disease diagnosis. Patients were eligible if aged 40 - 75

who had recently visited a primary care doctor or urgent care facility. The patients had a
spirometry test performed 4 to 5 weeks following an acute respiratory tract infection
diagnosis. All patients showing airway limitation were given a Beta2-agonist

(formoterol) through an inhaler. The COPD diagnosis was made according to the GOLD
standard. Of the 138, patients 38 patients were diagnosed with COPD. The study
suggested that assessing three simple variables: age, smoking status, and smoking
intensity with any patient with an acute respiratory tract infection could effectively

determine who needs a spirometry test. The study concluded that patients aged 40 and

over with a positive smoking history (over 20 packs/year) who develop any respiratory
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infection might be at risk of having COPD (Sandelowsky et al., 2011). Other studies
have shown that the underdiagnosis is because of a doctor’s delay who does not suspect
COPD because the patient may self-report that they are in good health (Hvidsten et al.,
2008).
Hvidsten, Storesun, Wentzel-Larsen, Gulsvik, and Lehmann, 2008, wanted to
determine the frequency and predictors of the undiagnosed chronic obstructive

pulmonary disease in Norway. A total of 3,506 participants who had respiratory

symptoms filled in questionnaires identifying their COPD symptoms, if they had a
smoking history, socio-economic status, self-reported health, and cardiac conditions. A

spirometry test was performed after inhaling 400 jug of salbutamol. It was determined

that 66% were undiagnosed, and that every two out of three patients in Norway are

undiagnosed with COPD. The results were not surprising as people with mild COPD
have few non-intense airway symptoms and do not seek the physician’s care. The three

variables, anthropometric, socioeconomic status, and cardiac comorbidities were not

associated with having COPD. The risk factors for not being diagnosed with COPD
included having a moderate reduction in lung function, not having COPD symptoms, and

reported being in good health (Hvidsten et al., 2008).
Readmissions
One in five people enrolled in Medicare will be readmitted to the hospital within

30 days, and it has been identified that up to 75% of these readmissions can be prevented.

A study completed by Jenks, Williams and Coleman, 2009 reviewed records from
13,062,937 patients and 4,926 different hospitals. The top 10 reasons for hospitalization
were reviewed, the readmission rate for COPD patients was 36% and all other reasons
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was on average 25 %. Fifty percent of those readmitted after discharge from a medical
condition do not follow-up with a medical doctor visit between discharge and

readmittance. These unplanned preventable readmissions can cost the United States
healthcare system approximately 17.4 billion in a year. This does not include

readmissions to the emergency room, urgent care facilities, or going to a different
hospital (Jencks, Williams, & Coleman, 2009).

It has been recognized that expenditures for preventable rehospitalizations may
be higher than $12 billion a year (Med Pac, 2020). An important element of the
Affordable Care Act was to reduce rehospitalizations. A proposal was developed to

change the accountability of a hospital for metrics for patient outcomes after discharge.

A Med Pac report was developed as a study in 2007. The three key questions were asked

in dealing with readmissions: What is the frequency of unplanned hospitalizations within
30 days after discharge? How long does the elevated risk of rehospitalization last? What

is the frequency of visits with a physician after a patient is discharged from the hospital
(Jenks, Williams & Coleman, 2009)?

The Med Pac report statistics indicated that 19.6% of the 11,855,702 Medicare
beneficiaries discharged from a hospital were readmitted back to the hospital within 30

days, 34% were readmitted back to the hospital within 90 days. Nearly fifty percent were
discharged with zero follow-up care. The average stay of rehospitalization was almost a
day longer than their initial visit. It was found that rehospitalizations among Medicare
beneficiaries are very prevalent and are costly to the health care system. The ten most

frequent reasons for each diagnosis-related group (DRG) were calculated. It was found
that COPD was the third highest DRG behind heart failure and psychosis. Conditions
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related to readmission in COPD patients included: respiratory or breathing problems,

gastrointestinal problems, metabolic or nutritional issues, cardiac arrhythmias, and acute
myocardial infarction. The DRG’s were not evaluated on the severity of illness. Upon

completing the report interventions could reduce readmission rates at the time of
discharge. (Jenks, Williams & Coleman, 2009).
In efforts to support the results of this study with research factors will be

identified that may contribute to the 30-day readmissions of those patients with COPD.
Readmission in general, can be related to many factors that have been described in the

literature review in diagnosis and assessment, management of COPD, challenges with the
management of COPD, misdiagnosis, underdiagnosis, readmissions, hospital discharge

and readmissions, post-discharge care, effective discharge planning/transitional care and
prevention and maintenance.

The research on home health care agencies and 30-day readmissions began to be

publicly reported in 2019 (Middleton, Downer, Haas, Knox, & Ottenbacher, 2019).
Home health agencies provide services to patients discharged from the hospital and
considered home bound and need skilled nursing therapy (Medicare Payment Policy,

2020). Medpac, 2020 cited that average about 29% of those discharged to home health
care result in 30-day hospital readmissions. This measure was not risk-adjusted on
severity. The results of this study indicate that 30-day readmissions of COPD at SUCH
are below the national average, according to Medpac, 2020. Based on how the statistics
are calculated results may vary. The agency for Healthcare Research and Quality

calculated the rate of per 100 index stays. The 7-day readmission rate for COPD patients

was 6.1%, and the 30-day readmission rate was 20.1% (Fingar, Barrett, & Jiang, 2017).
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The readmission rate for those COPD patients that readmitted back to SUCH is higher by

2.17% (Fingar, Barrett & Jiang, 2017). Although the statistics vary, the intent of this
study is to develop a discharge planning process that will benefit COPD patients and

reduce 30-day readmissions.
Of the characteristics reported to predict readmissions, Wong & Wilkinson, 2020

studied the risk factors for readmissions, including comorbidities, physical activity and
frailty, lung function, nutritional status and body mass index, social factors, hypercapnia,
and biological mechanism and biomarkers, medications, treatment, interventions such as
pulmonary rehabilitation, oxygen therapy, palliative care, self-management plans and

home health care which is referred to hospital at home in this study. It was stated that the

search needs to continue for interventions that are sustainable and can be applied to
diverse populations (Wong & Wilkinson, 2020).

There was a lack of consensus in the multifaceted problem of identifying the
factors that would prevent readmission and the system identification of post-discharge
care. Because of the lack of agreement in the research and limited research on small
urban community hospitals in the center of a major city, run as a non-profit, and a

teaching hospital affiliated with universities but not connected to a hospital, it was
important to evaluate the patients that readmitted at SUCH within 30-days characteristics
using the covariate scoring chart in Table 3.1.

Additional patient factors for the readmission of COPD patients include patients
that use oxygen at home, hypercapnia, comorbidities, systemic corticosteroid use,

smoking, and drug use. Poor access to health care included not having a primary care

provider, transportation issues, and language barriers. Efforts need to be made to analyze
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and synthesize medical evidence, follow clinical guidelines, identify best practices of

care delivery, and establish goals for improving the care process by assessing the quality
of care and readmissions (Jenks, Williams & Coleman, 2009).
Rezaee et al., 2017, examined 30-day readmissions through an emergency

department. A retrospective study was done on patients presenting with COPD over the
age of 18 in a large health care system in Michigan. Predictors identified were

demographics to include age, gender, race, insurance, marital status, and smoking status.
Clinical data collected was arterial blood gas, BNP, height and weight, oxygen saturation,

method of oxygen delivery if any, COPD medications, time in the emergency
department, prior inpatient stays, and length of stay. A multivariate logistic regression

model was used to evaluate the variables. It was found that those patients that presented
with breathing difficulty that albuterol utilization, smoking, and an increased pulse rate

were independent predictors of readmission (Rezaee et al., 2017).

Some of the factors associated with increased risk of readmission within 30 days
include male gender, African American, low BMI, discharge to post-acute care,

eligibility for Medicare/Medicaid, having an elevated serum arterial blood carbon dioxide
(pCO2), alcohol and drug use. Some of the comorbidities include congestive heart
failure (CHF), chronic renal insufficiency, diabetes, and psychiatric issues including
depression; and anxiety (Shah, Press, Husingh-Scheetz & White, 2016).
Fingar, Barett & Jiang, 2017 did a comparison of all cause 7-day and 30-day

readmissions. The Healthcare Cost and Utilization Project (HCUP) provided statistical
data for the top 20 principal diagnoses with the highest 7-day and 30-day readmission

rates. The highest principal diagnosis at the index stay was congestive heart failure
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which was ranked #1 with a 30-day readmission rate of 23.2%. COPD was ranked #9
with a 30-day readmission rate of 20.1%. The data percentages in this study were based

on per 100 index patient stays (Fingar et al., 2017).
Of the characteristics reported to predict readmissions Wong & Wilkinson, 2020

studied the risk factors for readmissions including: comorbidities, physical activity and
frailty, lung function, nutritional status and body mass index, social factors, hypercapnia,
and biological mechanism and biomarkers, medications, treatment, interventions such as
pulmonary rehabilitation, oxygen therapy, palliative care, self-management plans and

home health care which is referred to hospital at home in this study. The top ten reasons

for readmission included: respiratory failure, pneumonia, congestive heart failure,

asthma, septicemia, cardiac dysrhythmias, fluid and electrolyte disorders, intestinal
infection and non-specific chest pain (Wong and Wilkinson, 2020).
Kong and Wilkinson (2019) investigated models predicting readmissions for

exacerbations of COPD. Five different models were reviewed including: Age, dyspnea,
airflow obstruction (ADO); body mass index, airflow obstruction, dyspnea, exacerbation
(BODEX); dyspnea, obstruction, smoking, exacerbation (DOSE); length of hospital stay,

acuity of admission, comorbidities, emergency department use (LACE); and previous
admissions, extended Medical Research Council dyspnea score, age, right sided heart

failure, left-sided heart failure (PEARL). Kong and Wilkinson (2019) wanted to
understand the mechanisms that heighten the risk of having an exacerbation of COPD.

These models helped stratify the highest risk groups for target treatment (Kong &
Wilkinson, 2019).
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Biomarkers are needed to detect disease activity and severity to guide clinical care
and prognosis. The PEARL scoring index was proven to be easily applied and an
effective diagnostic aid to stratify the risk for readmissions of COPD patients. The

PEARL scoring index was superior to the ADO, BODEX, LACE, and DOSE (Kong &
Wilkinson, 2019).

Sickler, Wang, Chawla, and Nigam, 2015 examined risk factors in predicting
readmissions in COPD patients. The study was done to determine any clinical, socio
demographic factors and member character level factors associated with hospital

readmissions in COPD patients. They also wanted to identify those patients at high risk
for two or more hospital readmissions within six months after discharge. The study

evaluated two years of patients with an index admission for a COPD-related condition in
Southeastern Pennsylvania. COPD patients were identified using clinical diagnosis as
defined by the Centers for Medicare and Medicaid Services. According to the Centers
for Medicare and Medicaid Services, COPD is “an umbrella term used to describe
progressive lung diseases including emphysema, chronic bronchitis, and non-reversible
asthma. COPD is characterized by a chronic cough, increasing breathlessness, and
wheezing. It is associated with increased morbidity and mortality” (Centers for Medicare
& Medicaid Services, 2019). Readmission was defined as: “two or more all-cause

hospital admissions within six months after the index admission” (Centers for Medicare
& Medicaid Services, 2019). Of the 7,206 patients, 7.7% had two or more readmissions

in 90 days and found that the following were predictors of readmission: home oxygen
use, B-type natriuretic peptide test, quinolone antibiotic use, and patient education level.

The highest predictive variables were emergency room (ER) visits, cellulitis, myocardial
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infarction, renal disease, diabetes, and low education level. This study identified what

factors improved their ability to identify COPD patients at the highest risk for

readmissions. Outreach programs were developed to prevent future readmissions
(Sickler et al., 2015).

Many factors have been shown to affect the 30-day COPD readmissions, and
some hospitals have shown success in reducing their rates by applying these factors.

Because of the penalties for excessive readmission, this can negatively impact the
hospital’s revenue if operating on a narrow profit margin. According to a comparison of
the healthcare industry statistics, 2,573 hospitals in the fiscal year 2018 were penalized
due to the Diagnostic Related Group (DRG) reimbursement system (Pruitt, 2018).

As mentioned previously, having different ICD codes using DRG code used for
COPD is 088 and, in the ICD-9 codes, the codes used for COPD are 491, 492, and 494.
“ICD-10 codes related to COPD include J40 (bronchitis not specified as acute or

chronic), J41 (chronic bronchitis), J42 (Unspecified bronchitis), J43 (Emphysema), and

J44 (Other chronic obstructive pulmonary disease)”. There are charts that define the
links between ICD-9 and ICD-10 codes. When a hospital has different codes associated
with COPD, it can be difficult to interpret how different strategies can lead to
improvement (Pruitt, 2018).

A comparison of the number of comorbidities and readmissions was completed.

It was identified that comorbid conditions associated with readmissions were
cardiovascular disease, lung cancer, metabolic syndrome, osteoporosis, skeletal muscle
dysfunction, anxiety, and depression (Global Initiative for Chronic Obstructive Lung

Disease, 2019). Risk factors identified for 30-day readmissions were heart disease, male
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sex, depression, socioeconomic status, living in a nursing home, anemia, hyponatremia,

elevated PCO2, having a prior hospitalization, a longer length of stay (LOS), being on
oxygen therapy long term, low serum magnesium, and elevated C-reactive protein

(Global Initiative for Chronic Obstructive Lung Disease, 2019). New identifiable factors
are sleep apnea, electrolyte imbalance, acid/base disorders, vertebral fractures, low health

literacy, and substance abuse issues. Because there is no consistent set of guidelines that
help with the diagnosis and treatment of COPD it is difficult to have consistent study

results (Global Initiative for Chronic Obstructive Lung Disease, 2019).

There are an estimated 50 to 70 million Americans that have some sleep

disturbance (CDC, 2020). Males have a prevalence of 10% to 17%, and women have a
prevalence of 3% to 9% for obstructive sleep apnea (Global Initiative for Chronic

Obstructive Lung Disease, 2019). Studies show that 82% to 93% of individuals with
moderate to severe sleep apnea are not aware that they have the condition, and it remains

heavily underdiagnosed (Foldvary-Schaefer, 2019). Patients may not be aware of their
condition since they may have a controlled environment (Eagan, Knutson, Pereira &Von

Schantz, 2016). Sardar, Sufyan & Javed, 2019, reflected on the fact that there is a high
cost to the test, unavailability of appointments and lack of public awareness of the
disease. Kapur et al., 2017 suggested the following guidelines to patient that have COPD

with sleep disturbances; the recommendation is very strong to have a home sleep apnea

test especially if a patient has cardiorespiratory disease, respiratory muscle weakness,

hypoventilation, chronic opioid medication use, history of stroke or insomnia with
patients that have COPD (Kapur et al., 2017).
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Some programs were developed to reduce readmissions with COPD patients.
Better Outcomes through Optimizing Safe Transitions (BOOST), Project Re-Engineering

Discharge (Project RED), Care Transitions Intervention, and the Transitional Care Model

(Hansen et al., 2013). These programs help promote adherence to practice guidelines,
patient medication adherence, self-management practices for patients, phone calls within
24 hours to patient’s post-discharge to assess how they are doing with their care plan and

to check on symptoms and referrals to see if ambulatory programs have been completed.

Unfortunately, the programs did not address issues with proper use of inhalers,
supplemental oxygen, and pulmonary rehabilitation (Hansen et al., 2013).
Simmering et al. 2016, evaluated COPD patients with the highest risk of

readmissions. Many hospitals use COPD hospitalizations as a performance measure of
COPD care. The Healthcare Cost Utilization Project State Inpatient Database was used

for the years 2005 to 2011 to examine the risk factors for readmissions without age or
insurance restrictions. The data set included 17,918,374 patients from 480 hospitals
accounting for 28,265,070 visits. The patients were identified as having a primary

diagnosis of COPD aged > 40 years of age and alive at discharge. The study findings
indicated that younger patients aged 40 - 60 years old were more likely to be readmitted
and when there was a winter spike in weather, especially in January (Simmering et al.,

2016).
Home health care was the highest discharge status, and the highest comorbidities
were congestive heart failure, hypertension, diabetes, electrolyte disorders, and anemia.

It was also found that people with conventional insurance are less likely to be readmitted.
Other factors were related to socioeconomic factors and comorbidities (Simmering et al.,
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2016). Patients who were assigned home health care or that left against medical advice
were more likely to be readmitted in 30 days than those discharged to home with self

care or a skilled nursing facility. It was also noted that they would be less likely to be
readmitted for those discharged and provided home health services if they had a longer

length of stay during their first admission. It was suggested that extra efforts should be
made to refer patients to pulmonary rehabilitation for symptom improvement. Specific

limitations to the study did not record the patient’s current smoking status, access to
specific laboratory results and imaging, and pulmonary function testing which would give
COPD staging and medication use (Simmering et al., 2016).

Press, Konetzka and White, 2018 did a study on the economic impact of COPD
readmissions and the implementation of the Hospital Readmission Reduction Program

(HRRP). Press et al., 2018 identified that younger patients on public insurance are at a

higher risk for readmissions and supported the results of Simmerling et al., 2016. This
study identified factors that may place patients at a higher risk for readmissions and

whether or not intervention costs are outweighed by the financial impact of HRRP. There
have been variable findings on interventions and cost savings but cost analysis was not

provided (Press et al., 2018).
Rinne et al., 2017, examined the association between COPD readmission rates,

hospital characteristics and hospital quality. The study included 3,705 hospitals
nationwide that had publicly reported data on COPD readmissions. COPD was compared

with other conditions such as pneumonia, heart failure, myocardial infarction, stroke,
CABG surgery, and hip/knee surgery. Data was also evaluated on the patient experience

while in the hospital including factors of effective communication with doctors/nurses,
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responsiveness to needs, pain management, communication about medication, hospital
cleanliness, hospital quietness, provided discharge information, care transitions to home

or a facility, the overall hospital rating and whether the patient would recommend the
hospital to a friend or family member. Other factors evaluated were teaching status,

ownership, and safety net status. The lowest readmission hospitals were compared with
the highest readmission hospitals. It was found that the following variables were

consistent in the highest readmission hospitals, which included they were teaching

hospitals, private for-profit hospitals, and safety net hospitals (provide comprehensive
services to medically and socially vulnerable populations). The highest readmission rate
with patient experience was low scores on communication with nurses and doctors,

responsiveness, and pain management. More than 70% of readmissions were found to be
due to conditions other than COPD (Rinne et al., 2017).

According to the 2017 report on the Global Initiative for Obstructive Lung

Disease (GOLD), the most common comorbid conditions include cardiovascular disease,
skeletal muscle dysfunction, metabolic syndrome, osteoporosis, depression, anxiety, and

lung cancer (Global Initiative for Chronic Obstructive Lung Disease, 2019).
Categorically, COPD affects minorities and those with low socioeconomic status. The

hospitals such as small urban community hospitals, primarily teaching hospitals that care
for the underserved, will have higher readmission rates and more penalties through CMS
(Brahman, 2015). The factors associated with Medicaid insurance include low income,
lack of social support, unstable home environment, being unmarried, smoking, cocaine

use, low health literacy, poor nutrition, lack of follow-up with a primary care doctor, and
medication compliance (Calvillo-King et al., 2013).
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Hospital Discharge and Readmission

Discharging patients from the hospital can be a complex process that presents

many challenges. Unplanned readmissions cost hospitals 15 to 20 billion dollars
annually (Alper, O’Malley, & Greenwald, 2019). Finding ways to improve the quality of
life for patients and finding ways to improve the financial well-being of health care

systems has become difficult. Various approaches have been researched to improve the
discharge process, including pre-discharge interventions providing patient education, pre
discharge planning, medication reconciliation and education, the scheduling of follow-up

appointments before leaving the hospital and completing post-discharge interventions
(follow-up phone calls, communication with the care provider, and home visits), merging

interventions with transition coaches, discharge specialists, and providing clinician
continuity between the inpatient and outpatient settings (Alper, O’Malley, & Greenwald,
2019).

The continuation of hospitalization is determined by an acute health condition.
The degree of severity that diagnostic testing, interventions, and monitoring have
determined is necessary. Patients are sometimes kept in the hospital because of not
having a suitable alternative setting to provide care. Some patients are discharged
prematurely or to a living environment that is not appropriate for their needs, and hospital

readmission recurs. An early patient discharge does not lead to cost savings for the

hospital, especially when it results in hospital readmission (Kripalani, Theobald, Anctil &
Vasilevskis, 2014).

When a patient has been recommended for discharge, the most appropriate setting
that would benefit patient needs is determined. Some post-discharge care setting

53

determinants involve the medical, operational, and social aspects of the patient’s illness.
The patient’s health history, the potential for rehabilitation, and the ability to make
decisions must be determined. People involved in the decision include the patient,
healthcare POA, the family, social worker, case manager, physician, physical and

occupational therapist, and the insurance company. The following factors need to be
considered: patient’s cognitive status, activity level, and functional status, the patient’s
home, considering the presence of stairways and cleanliness, family support, ability to

follow instructions with medications, transportation to and from follow-up visit and
testing, and the availability of services in the local area to assist the patient with follow

up care (Kripalani et al., 2014).
Approximately 75% of patients hospitalized can return to their homes post

discharge. Patients and their family or caregivers should obtain and administer
medications, perform self-care activities, eat a nutritional diet, and follow up with
physicians. Suppose patients may need non-acute medical care to manage their home

health need. In that case, a patient may be discharged to another care facility prior
arrangement to an inpatient facility must be arranged for ongoing care through the facility

and insurance company. Determining the most appropriate care setting requires matching
the needs with the patient’s diagnosis (Kripalani et al.,2014).

Medicare identifies three health facilities: acute care hospitals, long-term acute

care hospitals (LTACs), and skilled nursing facilities (SNFs). For purposes of this study,

LTAC and SNF will be described. Long-term acute care hospitals must maintain a length
of stay of 25 days or greater. Patients must require daily monitoring and complex
medical interventions such as complex wounds, chest tubes, ventilatory devices, and have
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multi-organ failure. The number of LTAC facilities has more than doubled since the late

‘90s. A skilled nursing facility has more of a facility that is comparable to a hospital.
Patients must have a qualifying event that includes a 3-night hospital stay and must
require nursing or rehabilitation for one hour five days a week. In addition, home-based

services or home health care is a highly variable service. Home-based services can be

provided by Medicare-certified home health care agencies, private duty nursing services,
infusion services, hospice, clinician home visit programs, and telemedicine (Kripalani et
al., 2014).

The impact of discharge planning on outcomes is minimal. In 2010, Sheppard et
al. did a review of patient satisfaction, length of stay, and readmission with different

modes of discharge planning. It was observed that there was an increase in patient

satisfaction while the length of stay and mortality rates were unchanged (Sheppard et al.,

2010). Jha, Orav, & Epstein 2009, examined discharge planning for patients with heart
failure measuring the chart documentation of discharge instructions and patient reports on
discharge planning. There was no correlation found between readmission rates and the

chart-based measure, and there was an extremely low correlation for lower readmission
rates (Jha, Orav & Sheppard, 2009).

Post Discharge Care

In an ideal health care system, the patients that are discharged would get the
needed appropriate care in their community. Readmissions can be avoidable after hospital

discharge. With better clinical management, stabilizing the patient before discharge,
having adequate outpatient care after discharge, appropriate discharge planning,

education, and providing resources at home that meet the patients’ needs can help with
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management of their disease. The dietary and medication non-compliance of patients and

the failure to seek prompt medical attention from their primary care physician when
symptoms occur are all factors in being readmitted back to the hospital. It was addressed

in Yam et al., 2010 that it is essential to have a consistent methodology/instrument with
valid criteria that can be applied in context to determine the plan of care and how
readmissions can be avoidable (Yam et al., 2010).
Yam et al. (2010) studied 603 patients performing an evaluation of patient
characteristics, clinical data, physical and cognitive function, and discharge information.

The average age was 74.8 years of age; 53.2% were male and spent an average of 9 days

in the hospital during their index admission and seven drugs during discharge.
Sixty-five percent were discharged home, and 69% had to follow up at clinics with a

specialist, 8% at a general clinic, and 17.4% at sub-acute care clinics. A total of 38.6%
walked independently, and 33% walked with support. A total of 56.8% were readmitted,

the principal diagnosis at readmission included: ill-defined condition 15.4%, chronic

obstructive pulmonary disease 12.3%, pneumonia 11.3%, heart failure 6.8%, ischemic
heart disease 4.6%, cancer 3.2%, renal failure 3.0%, cardiovascular disease 2.0% and
diabetes 1.5%. Thirty-two-point-eight percent had the same principal diagnosis in the

previous discharge. The avoidable readmissions were 246/603. The factors identified in

how it was considered due to clinician factor (42.3%), low threshold for admission
(10.6%), premature discharge (9.3%), and medication-related event (7.7%), poor
discharge planning (14.6%), and inadequate terminal care (4.1%). The study results gave

insight into developing a discharge planning system (Yam et al., 2010).
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The five main contributors identified in gaps in care transition include poor
preparation for discharge, patients with low health literacy and comprehension, failure, or

inability of patients to see physicians for follow-up after release, lack of hospital follow

up, and lack of communication between inpatient and outpatient providers. Preparation
for patients to leave the hospital is inadequate. Many hospitals are characterized by
fragmented, non-standardized, and haphazard care. Nurses and first-year residents are
often placed in consideration of a patient discharge. Discharge is of low priority when

many other duties may have importance, especially when staffing is inadequate due to
hospitals controlling for cost. There are no clear lines of authority in the discharge

process. This sets up the individual to fail and creates a dangerous situation for the patient

(Naylor & Keating, 2008).
It has been said that nearly 90 million Americans have low functional health
literacy. Patients have difficulty reading and understanding medical instructions, medical
labels, appointment slips, and getting patients to understand what is required after
discharge is difficult. Most patients do not understand their diagnosis, their treatment,

home care instructions, or warning signs to call their physician or go to the hospital. At
the time of discharge, residents or nurses may rush through education, and the patient

may not ask questions. Most of the time, the caregiver needs to receive the instructions

(Naylor & Keating, 2008).
Kripalani et al. (2007), describe the deficits in communication and information
transfer between hospitals and primary care physicians for the continuity of care. Direct

contact between the hospital and primary care physicians (PCP’s) only happens in 20%

of cases. Only 12-34% of PCP’s receive a patient’s hospital discharge summary.

57

Approximately 40% of patients have pending test results at the time of discharge,

and 10% may require following up with a specialist according to the test results. When a

patient hospital summary is not forwarded to the PCP, they may not know the hospital
visit details and go by assumption because patients are often poor historians (Kripalani et
al., 2007).

The fundamental changes mentioned in the literature are developing an assessment

of the patient's post-discharge needs, including effective teaching and learning by patients
and caregivers, improved communication with the PCP, and assurance of hospital follow

up. The Naylor Transitional Care Model suggests care coordination by a transitional care
nurse, which reduced hospital costs by 39 percent and the number of readmissions by 36

percent (Kripalani et al., 2007).
Alper et al., 2021 completed a literature review on hospital discharge and

readmissions. It was found that not all care alternatives can meet a patient’s needs or
insurance may deny the intended referral. For example, if a patient is referred to a SNF

and their insurance company denies the claim, the patient would then be referred to HHC.

Some factors that may influence readmissions while being discharged to home or while
HHC is active is the inability of the patient to self-administer medications, not being able

to complete activities of daily living, not having a nutritional diet, and lack of follow-up

visits after a hospital stay (Alper et al., 2021).
Yam et al., 2010 found actors in those patients that readmit from HHC may
include a decreased length of stay to avoid Medicare penalties. A patient that is

discharged to home health care may have some advantages due to the fact that a nurse
goes to their home to help the patient with their care and to help them get stronger (Jha,
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Orav, & Epstein 2009). The downside is that patients are not able to get out of the house

without significant difficulty, and patients are isolated (Kripalani, Theobald, Anctil &
Vasilevskis, 2014).

The consequence of the patient not being able to follow their discharge plan such
as receiving duplicate medications they have at home, having a different name, not filling

their medications immediately following discharge, having tests pending at discharge that
were never reviewed or documented in the discharge plan, poor information transfer from

hospital providers to patient or caregiver, lack of follow-up care, some readmissions are

obviously unavoidable due to underlying conditions exacerbating their COPD (Naylor &
Keating, 2008).
Many patients that are admitted to SUCH may wait until the very last minute to go

to the emergency room when having symptoms of cough, sputum, and tiredness upon

exertion, so these patients tend to be sicker when evaluated versus going to their primary

care physician when there is an initial onset of symptoms (Quach et al., 2012). In turn,
these patients are entirely bedridden during their hospital stay and refuse physical therapy

and getting out of bed when requested to, so patients become deconditioned quickly

(Fried, Frangoso, & Rabow, 2012). Therefore, there may not be an appropriate full
evaluation of the patient with the patient not receiving enough testing (Fried, Frangoso &
Rabow, 2012). The nursing staff may determine that the patient needs continued inpatient

services upon discharge to include physical/occupational therapy in the home (HHC) or
to a skilled nursing facility (SNF)/long-term care facility (LTAC) (Kelley, Docherty &
Brandon, 2013).
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Yam et al. (2010) stated that better clinical management, stabilization before
discharge, and adequate outpatient care as part of discharge planning could meet the

patients’ needs according to their evaluation. The use of guidelines and an assessment

instrument may give insight to physicians and nurses regarding the total health of the

patient and how that patient can communicate their condition(s) (Eikermann et al.,

2014). Patients need to communicate to a healthcare worker effectively to increase the
reliability and validity of the patient assessment (Eikermann et al., 2014). The physicians
and nurses need to understand the patient complaints appropriately to decrease the risk of

health issues reoccurring (Kelley, Docherty & Brandon, 2013).
While limited socioeconomic resources contribute to higher readmission rates in a
hospital that primarily treats a vulnerable patient population, this study reveals that there

may be some gaps in-hospital treatment, discharge, and a discharge care pathway (Hu,
Gonsahn & Nerenz, 2014).

Effective Discharge Planning/Transitional Care

Transitional care refers to collecting services to provide optimal communication
and coordination of services to provide a quality continuum of care for patients

(Mularski et al., 2006). Accountability breakdowns occur when there is no coordination

of the patient’s care across various settings, mainly from hospital to home. With more
complex patients, specialists may not communicate effectively with the patient and their

caregivers. There is a need for care models in pre-discharge and post-discharge periods
that increase the patients best care (Mularski et al., 2006).

Prieto-Centurion et al., 2014 completed five trials in six countries with a total of

1,393 participants. Readmissions were evaluated at 6 and 12 months. Each trial evaluated
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up to 11 interventions used as a treatment bundle during the pre-discharge and post
discharge periods. Each of the five trials included patient education, which had

instruction on the use of respiratory inhalers, the development of an action plan if
symptoms worsen, and patients were given a number to call after discharge if symptoms
persisted. Other interventions included discharge planning, patient education about

COPD, health counseling, smoking cessation, assessments for comorbidities, referrals to
pulmonary rehabilitation, and social services (Prieto-Centurion et al., 2014).
There was a significant drop in COPD readmissions at six months and more
noticeably at 12 months. However, there was no statistical significance that supported a

reduction in 30-day readmissions. The most effective interventions in the study were the
follow-up telephone call and the patient hotline. There is a suggested need for an

interprofessional care model to implement intervention bundles before and after
discharge (Prieto-Centurion et al., 2014).
Initiatives that improve inpatient quality without making improvements in

ambulatory care could unexpectantly increase hospital readmissions. Some factors are not
modifiable with underserved patients, such as income, insurance, and coexisting
conditions such as mental issues. The HRRP program penalizes the hospital for 30-day

readmissions. In 2013, CMS developed a physician payment rule that incentivized
ambulatory care providers to participate in transitional care management (TCM). For a
physician to bill for these payments, they must provide three critical services, including

contacting a patient within two days of hospital discharge, they must have a face-to-face
visit with the patient from 7 to 14 days of discharge, and they must provide indicated care

coordinated services during the 30 days after discharge. The TCM codes are not restricted
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to any disease but used only for discharged patients to home. It was determined that the

TCM codes could improve patient experience and improve health outcomes (Kangovi &

Grande, 2014).
De Regge et al., 2003, completed a systematic literature review investigating how
hospitals can bridge the care continuum. People today suffer from chronic diseases that

can negatively impact their daily lives. The coordination of care requires long-term
planning with many different healthcare professionals. The coordination is involved with
the hospital, primary care provider, and community-based services. Hospitals need to

work closely with community partners to avoid hospital readmissions. Hospitals need to
shift from an acute care model to more of a chronic care model. Health policy has

determined the reduction of length of care for a patient that has a long-term condition.
Chronic illness management in an acute care environment is essential to managing COPD

(De Regge et al., 2003).
Within the literature review, there was a comparison of outpatient care versus
home-based care. De Regge et al., (2003), stated that caring for patients in their homes

was more expensive and less effective. It was also found that the incidence of
readmissions was higher when there is a shorter length of stay in COPD patients. This

study supports case managers and patient care team’s necessity in the intervention of
those with chronic illness in an acute care facility (De Regge et al., 2003).

Prevention and Maintenance
Beyond the interventions mentioned throughout this study, some of the key issues

in prevention are smoking cessation, annual influenza vaccination, and pneumococcal
vaccination for all patients over the age of 65. Other management plans include proper
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pharmacologic therapies with an emphasis on appropriate inhaler selection and inhaler
technique. Rehab, education, and self-management are all essential to monitor the
symptoms of patients and monitor airflow limitation. It is necessary to contact the patient

to modify the care plan to uncover complications and other symptoms that may develop
(Rinne et al., 2017).

Smoking Cessation
Smoking cessation is key to maintenance therapy when managing COPD.

Pharmacotherapy and nicotine replacement increase the chances of successfully

abstaining from the smoking habit. The effectiveness of e-cigarettes and using vape
methods is unknown, along with the long-term effects of these modalities for quitting.
Legislative smoking bans have effectively increased quit rates and reduced the harm to

others with secondhand smoke. Nicotine replacement therapy (nicotine gum, inhaler,
nasal spray, patch, tablets, or lozenge) increases long-term abstinence rates.

Counseling delivered by clinicians or healthcare professionals can significantly
increase quit rates over self-directed strategies (United States Public Health Service,

2008).

Vaccinations
Having a patient get an influenza vaccination can reduce serious illnesses such as

lower respiratory tract infections in COPD patients (Alfageme et al., 2006). Very few

studies have evaluated the incidence of exacerbations after influenza vaccination as they
have become beneficial for elderly patients. It has been demonstrated that the
pneumococcal vaccine that was identified in 12 randomized studies provided significant
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protection against community-acquired pneumonia. Vaccinations were found to

significantly reduce the likelihood of a COPD exacerbation (Alfageme et al., 2006).
Pharmacologic Therapy

Pharmacologic therapy is used to reduce the symptoms of COPD patients, the

frequency and severity of exacerbations, and they also improve health status and the
ability to exercise. There are several classes of medications that are used to treat COPD.
Choices are based on the availability and cost of the medication as well as clinical effects.

Bronchodilators will increase the patient's FEV1 and can change spirometry values. They
alter the smooth muscle tone of the airway, also widening the airway. They tend to

reduce dynamic hyperinflation and improve exercise performance. Long-acting
bronchodilators given by a nebulizer appear to provide the most benefit in patients
(Montuschi, 2006).

Beta2-agonists are prescribed. This will relax the smooth muscle in the airway by

stimulating the beta2-adrenergic receptors. Short-acting (SABA) lasts 4-6 hours, and
long-acting beta2-adrenergic (LABA) lasts up to 12 hours. Beta2-adrenergic can produce
resting sinus tachycardia and cause cardiac rhythm disturbances. Hypokalemia can occur
when treatment combines with thiazide diuretics (Montuschi, 2006).

Antimuscarinic drugs block the bronchoconstrictor effects of acetylcholine on the

muscarinic receptors in the airways smooth muscle. It is found through a review of
clinical trials that a short-acting muscarinic antagonist (SAMAs) such as Ipratropium

provides substantial benefits in terms of lung function, health status, and the need for oral
steroids. Long-acting muscarinic antagonists (LAMAs) work and SAMA’s but have also

been identified to reduce exacerbations and improve the effectiveness of pulmonary
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rehabilitation. The SAMAs and LAMAs are considered anticholinergics. The main side
effect is dry mouth. Combinations of Beta2-Agonists and SAMAs, and LAMAs are often
prescribed (Montuschi, 2006).

Methylxanthines such as theophylline are used, which are metabolized by
cytochrome mixed-function oxidases. This medication enhances inspiratory muscle
function. Toxicity can be the most significant issue with methylxanthines because the

effects are often established with higher doses. Atrial and ventricular arrhythmias have

been noted as a problem with this medication. The most popular medicines distributed to
patients during their hospital stay at SUCH are Ventolin (SABA), Symbicort (LABA),

and Atrovent (SAMA). A combination of Albuterol Sulfate and Ipratropium Bromide

may be used and the addition of Symbicort (Montuschi, 2006).
Inhaled corticosteroids (ICS) suggest that COPD-associated inflammation has a
small response to corticosteroids. The safety of patients using ICS with COPD is unclear.

With just the treatment of ICS, it does not modify the FEV1 long term. In patients with

severe COPD, an ICS with a LABA is the most effective in improving lung function,
health status and reducing the number of exacerbations. When using an inhaler treatment,
education and training in inhaler device technique are critical. Many studies have
identified a significant relationship between low inhaler use and symptom control in
patients with COPD (Montuschi, 2006).

Rehabilitation, Education, and Self-Management

Linking health care professionals such as exercise physiologists, respiratory
therapists, nurses, dieticians, pharmacists, and physicians have demonstrated improved
outcomes (Derdak, 2017). Other examples of self-management include Facetime, Skype,
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tablet, or smartphone-based applications using digital diaries for symptom tracking, pulse
oximetry, peak expiratory flow, and inspiratory capacity monitoring (Derdak, 2017).

Silver, 2017 investigated 428 subjects with a high risk of readmission to compare
pre-discharge care versus comprehensive respiratory therapy disease management. The

study was restricted to subjects > 65 years old with prespecified risk factors for COPD
readmissions: previous emergency department visits, hospitalizations, systemic

corticosteroids within the last year, and supplemental home oxygen. The respiratory
therapist incorporated pre-discharge subject education, including proper inhaler and
medication use, patient follow-up clinic appointments, pulmonary rehabilitation, smoking

cessation education, and structured phone calls from the respiratory therapist. The key
findings indicated that those receiving comprehensive respiratory therapy disease
management experienced significantly fewer readmissions, shorter hospital stays, and
fewer ICU visits following discharge. This was a very low-cost program applied to a

diverse population of subjects (Silver, 2017).

Critical non-pharmacologic approaches include case management, patient

education with written action plans, smoking cessation, and pulmonary rehabilitation
(PR). Pulmonary rehabilitation should ideally start within 30 days of discharge from the

hospital. Despite the documented benefits of exercise and the reduction in shortness of
breath, enhanced physical endurance, patients were not using pulmonary rehabilitation,

which created a gap in their quality of health care. Most patients are not referred, yet it is

proven to improve life, depression, self-efficacy, and exercise activity. Pulmonary
rehabilitation reduces dyspnea, muscle fatigue, anxiety, and panic (Johnston & Grimmer-

Sommers, 2010).
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CHAPTER III

METHODS
Study Design

A retrospective descriptive research design was chosen for data collection at a
small urban community hospital (SUCH) in Cleveland, Ohio. With this type of

investigation, the phenomena existing in the present are linked to other events in the past

before the study was initiated. The goal of this study is to determine the association
between post-discharge care settings (home with self-care, home with home healthcare,

skilled nursing facility, and long-term care hospital) and 30-day readmission rates of
chronic obstructive pulmonary disease (COPD) patients and to identify the covariates

(patient characteristics) that are shown by severity to have the most influence between
those that readmit and those that do not readmit. If there is statistical significance
between post-discharge care settings (HSC, HHC, LTAC & SNF) a further evaluation of

variables will be performed. The independent variable is post-discharge care setting, and
the dependent variable is 30-day readmission.

If differences in readmission rates are observed, patient characteristics (covariates
will be evaluated in an attempt to discern unique patient characteristics with the patients

that readmit the most at SUCH. Further this result will potentially provide the basis of
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establishing a clinical care pathway to recommend the care settings to patients where they
may have the greatest likelihood of avoiding 30-day readmissions.

Research Variables
Dependent Variable - Readmissions within 30 days of initial discharge.
Independent Variables - Post-discharge care settings (Discharge to home, home
with home healthcare, skilled nursing facility, long term care hospitals, and

covariates/groups of covariates.
Hypothesis/Research Questions:

RQ1: Is there a significant difference in 30-day readmission rates for the post
discharge care settings (discharge to home with self-care, home with home health

care, skilled nursing facility, and long-term care facility) in patients with COPD?

Ha1: There will be significant differences in patients who get discharged to

different post-discharge care settings (HSC, HHC, SNF and LTAC) who get

readmitted within 30 days after index admission with COPD versus those who do
not get readmitted back to the hospital within 30 days of their indexed admission
with COPD.

RQ2: Is there a significant difference in patient characteristics (covariates)
between those patients that get readmitted and those patients that do not get

readmitted?
Ha2: There will be significant differences in the characteristics (covariates) of
patients who get readmitted back to the hospital within 30 days of their indexed

admission and those that do not get readmitted with COPD.
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Participants
Participants were retrospectively recruited from SUCH, a 205-bed not-for-profit
hospital in Cleveland, Ohio, by searching for patients with COPD as the primary

diagnosis. The 30-day readmissions were also identified as having a diagnosis upon their

return to SUCH for COPD within 30-days of discharge. A SUCH is a teaching hospital
that is affiliated with but not attached with other medical schools and universities in and

around Northeast Ohio. The participants in this study all had COPD listed as a primary
diagnosis in their history and physical record documentation as identified by the clinical

documentation improvement department (CDI) and through a processed insurance claim
by Medicare, Medicaid, and conventional insurance. Data was only collected on subjects

over 18 years of age with COPD as the primary diagnosis.
Inclusion/Exclusion Criteria

Inclusion: Adults aged 18 years or older with the primary diagnosis of
COPD. Not limited to time, demographics, testing, symptoms, risk factors,

comorbidities, diagnostic group, or post-discharge care setting
Exclusion: Any patient that does not have the primary diagnosis of COPD or that
expired during the post-discharge time period.
Sample Selection

Figure 3.1 displays the process to identify the patient sample, which included the
selection criteria by which each patient was initially identified, what constituted a

readmission to be included in the evaluation of post-discharge care, and the readmission
criteria. Patients were selected from medical records based on the primary diagnosis of

COPD. CMS presented the COPD diagnosis's determination in May 2019 to include the
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diagnoses under ICD-9 and ICD-10 codes specifically (Centers of Medicaid/Medicare

Services, 2019). The count of COPD patients was identified by the following statement,
“Count of acute care inpatients (elective or nonelective) with a principal diagnosis of

chronic obstructive pulmonary disease, or principal diagnosis of respiratory failure and a
secondary diagnosis of chronic obstructive pulmonary disease (index population).”

The number of patients in the sample size from SUCH from July 1, 2014, to July
1, 2019, with a confirmed diagnosis identified by a processed insurance claim of a

primary COPD diagnosis (n = 1,016 patients). The total number of patients that were
readmitted back to SUCH with any diagnosis n = 1,996. The total patients diagnosed with
COPD that were readmitted within 30 days of the patients indexed admission n =155.
This sample was verified by including the diagnoses provided by CMS guidelines, and
then each patient was individually pulled from all readmit sample through excel filter
options. The total number of patients expired within their indexed admission time frame,

and 30 days totaled eight patients. Descriptive statistics are provided for the 30-day
readmission sample. All patients included in the sample were admitted to SUCH and

readmitted back to SUCH within 30-days of their indexed admission with a COPD
diagnosis. Patients admitted to another hospital and readmitted back to SUCH within 30
days or admitted to a hospital other than SUCH and readmitted back to SUCH within 30
days of their index admission were not included in the sample. All patients included in

the sample were older than 18 years of age. There was not an exclusion criterion given to
the readmission admitting source. Patients may have been admitted within 30-days from
home, another emergency department, SNF, healthcare facility, psych ED, physician’s
office, or an acute care hospital.
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Patients admitted to SUCH
from July 1, 2014 July 1, 2019
Quality departement
search of patients
admitted with COPD
n= 1016 patients

Patients with COPD as
their primary diagnosis.
If a patient admitted on
two or more separate
occasions they were given
separate identifiers

Figure 3.1 Process to Identify Patients and Readmissions
To represent the adult patient population of SUCH with a primary diagnosis of

COPD, convenience sampling of patients was selected. Subjects for this study were
extracted from patient data using the electronic medical record (EMR) system at the
small urban community hospital. The sample size was determined after the search was
performed using the primary diagnosis of COPD by the electronic medical records

(EMR) between July 1, 2014, and July 1, 2019. Data were obtained from the SUCH EMR

databases, and the patient lists were then forwarded from the CDI department for

analysis. To determine the 30-day readmission group, the patients were identified as
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having been readmitted to the hospital within 30 days with a readmission diagnosis of
COPD. To verify the patient list was accurate, a request was made for all patients that
were readmitted back to the hospital within 30-days of their indexed admission.

From there, Excel was used to filter out the COPD categories, and the names were pulled

and verified to the original list provided by the clinical documentation improvement

department.
Three lists were created, all patients with COPD as their primary diagnosis,
patients who readmitted back to the hospital within 30-days with a COPD diagnosis, and
those who did not readmit back to the hospital within 30-days with a COPD diagnosis.

From each list, all post-discharge settings were then put into separate categories to be

analyzed by characteristics. The post-discharge categories were home with self-care,
home with home health care, long-term care facilities, and skilled nursing facilities. A

comparison chart was then made to evaluate the total sample of individuals with a COPD
diagnosis, a total sample of individuals with COPD diagnosis that readmitted back to
SUCH within 30-days, the total sample of individuals with a COPD diagnosis that did not
readmit back to the hospital within 30 days and a chart for comparison of each post

discharge category that readmitted back to SUCH within 30-days of their indexed

admission.
The purpose was to capture the process and identification of the
patient/procedures related to the patient and how decisions were made according to the
disease severity and the choice of post-discharge care and 30-day readmissions.

The patients’ index admission diagnosis was again verified through a
retrospective analysis of a secondary medical record utilizing Meditech (Meditech
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Information Technology, Inc., 2019). Meditech is the hospital database used with all

initial patient documentation with intake, admission, patient stay, and discharge.
Each patient history was reviewed for diagnoses, hospitalizations, symptoms,
readmissions, tests, procedures performed, and emergency department visits. The specific

characteristics of the patients were identified in the demographics data to include age,

gender, race, living arrangements (marital status), insurance, number of diagnoses, and
zip code from which the patient lives, length of stay, number of diagnoses, discharge

location and physician specialty upon discharge. A chart for analysis of each category

was then created.
Because the study is a retrospective analysis, participant consent was not

obtained. A Small Urban Community Hospital Institutional Review Board Request for
Waiver of Informed and Authorization for Research form filed with IRB. The data was

for a retroactive study on discharged patients from SUCH. This research presented no
greater than minimal risk for patients and their medical records. There were no incentives
or compensation provided during this study.

An application requesting permission to conduct this study was submitted to a
small urban community hospital Institutional Review Board and Cleveland State

University Institutional Review Board. Permission to conduct this research was approved
through the Institutional Review Board at the small urban community hospital and
Cleveland State University. The memorandum for each has been enclosed as an
Appendix B and D. An application requesting permission to conduct this study as part of
the fulfillment of the doctoral requirement was submitted to Cleveland State University

Institutional Review Board. Approval was granted on March 21, 2019 Appendix D.
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An addendum was completed to add selection years, and another application was

completed to extend the study deadline Appendix C.

Data Collection
The clinical record/chart review included the following data sources: case notes,

inpatient case files, nursing records, pharmacy records, laboratory records, patient

monitor records, clinical information, and demographic records. The independent
variables/covariates were chosen based on literature reviews and the operationalization of
those variables in a variety of studies.

The data collection used medical information without the written permission of
the patient permission was granted by SUCH IRB. There was an adequate plan to protect

identifiers for use and disclosure, and the data will not be re-used or disclosed for another
purpose. The research for this study could not be possible without the use of the protected

health information. The data collection sheet is provided as Appendix G for this study.
The data was to be collected through the development of a coding program
through the IT department to extract the data. The data was individually collected based

on the history and physical assessment performed in the hospital-based on a COPD
diagnosis. An order was sent to the IT department, and it was decided that the data could
not be collected to the specifics of each category. As a result, the CDI department was

used to collect the data individually for each patient. At that point, the subjective,
objective, assessment and plan were reviewed to capture the picture of the patient during
admission, throughout their patient stay, and through discharge. A comparison was made

with the clinical documentation improvement specialists/coders to provide insight into
clinical findings and physician/resident behavior and validate the diagnosis.
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An excel spreadsheet for the covariates was prepared to extract all variables

determined. An excel sheet was used to populate the patient medical records after the
data was processed. Understanding that not all variables would be found within the data
compilation, some data will need to be abstracted by hand using computer records to

record newly found data.

A logical data extraction form was provided for the covariates' rational
organization, as shown in table 3.1. All co-investigators performing data collection were

provided with training explanations on how the review was to be done and how the
responses will be coded to error in variability. All co-investigators are medical doctors

completing their residency at SUCH. Based on the data compilations, a decision tree was
created for different coding situations that were foreseen. Standardization was crucial for
ensuring that the study is of sound quality. Inter-rater reliability was determined by

having different medial residents code the same set of variables. All data collectors were

responsible for adhering to federal law concerning patient health information. The study

was done on data that has already been recorded involved summarizing the data,

subjecting it to the appropriate statistical analysis, drawing inferences based on severity
levels, and recording that information appropriately.

The following was reviewed from the patient chart: history of present illness,
family/social history, allergies/home medications review of symptoms, physical exam,
and the assessment and plan of the patient. A well-designed coding plan was developed
to extract the data from the case records. It has been agreed upon as to which
variables/covariates are extracted and how the data is to be populated into excel
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spreadsheets. A small subsample was to be reassessed to check agreement with the
previously coded data to determine the pattern and extent of inaccuracies.

It was essential to recognize that the attempt for the data collection/analysis is to
capture the image of what is going on in the hospital in terms of the patient being

admitted to the floor, the initial assessment, the care of the patient, the medications
administered, the plan of care followed for, the discharge information and the post
discharge care determination. It is also imperative that it was recognized that different

individuals might operationalize signs and symptoms: intake specialists, nurse, physician,
resident, etc., and documentation will reflect this evaluation according to how it is
communicated by the patient and documented by the clinician. To increase the reliability
and validity of the variables under investigation, Appendix F will be included for a

glossary of definitions of the variables/covariates relevant to this study if needed.
Covariates

Table 3.1 represents the covariate chart risk scale to be used to determine risk
with each covariate for each patient with COPD. The chart will be used to evaluate the

characteristic, and are presented by a rating scale of 1 = mild, 2 = moderate and
3 = severe for analysis purposes. The covariates were chosen based on the identified

characteristics of many research studies investigated and through clinical guidelines used
for evaluation of a patient. The evaluation was done for all COPD 30-day readmissions

and non-readmissions. The purpose of the covariate’s evaluation was to determine

whether each characteristic influenced the outcome measure of 30-day readmission. The
significance was determined by each variable.

The significant variables were explained by analysis and analyzed according to

research and recommendations to provide a guided choice/direction for the Physician’s,
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Residents, Nurses, and Social Services that could potentially be used to better identify a
discharge care choice setting that could benefit the patient the most, and reduce 30-day

readmissions. The study's goal was to structure a process for post-discharge care that
generates a decision based on meaningful clinical data and research.

Table 3.1 Covariate Chart Risk Scale
Covari atesto be investigated in COPD patients th at re admitted within 30daysof indexed admission
Patient

ID

Covariate

Description

Score 1

Description

60-80
Family Support
5 Days
Only Medicare
3 or 4
2L or 3L
Stable
CPAP
120/80-140/90
1st FBG < 200 mg/dL
Quit 5 years +
Yellow
Increased
On exertion
PRN
89% to 93% or Less than 3L
Obese
Expiratory
4L 02 or CPAP
60-80 mm Hg
PCO2>45
Wthin 2 years of visit
Moderate - > 50 - 79%
Within 2 years of visit
> 40-50 EF
Moderate 41-55
Active Services
Walker/Rollator
One

Afie
<60
Living Arrangements
Married
Length of Stay
4 Days or Less
Insura nee
Private Insurance
Comorbidities
<3
Home 02
None
Previous CAD Disease
None
Sleep Apnea
None
Hypertension on Medication
No/Normal
Diabetes on medication
None
Smoking History
None
Sputum
White
Cough
None
Heart Failure sx on admission
None
LABA/ICS Drug combinations
None
SaO2 in 1st VS
94% to 100% RA
Weight Classificaton
Norma I/O verweight
Wheezing
None
Severity of Disease
Nasal Canula
Hypoxia/hypoxemia PaO2
80-100 mm Hg
Hypercapnia/hypercartia
None/Normal
Pulmonary Function Test
Yes
FEV 1
Mild ->80%
Previous Echo
Yes
Systolic Heart Failure
Normal EF
Right Ventricular Systolic Pressure
Mild 25-40
PT/OT During Hosp Stay
None
Adaptive Equipment
None
Exacerbations in the last year
None

Score 2

Description

Score 3

>80
Lives alone
6 Days or More
Medicaid
>5
4L or More
Symptomatic
BIPAP
Above 140/90
1st FBG > 200 mg/dL
Current Smoker
Green
Severe/Vomit
Orthopnea
Non-Compliant
< 89%/ > 4L 02/CPAP
Morbid Obesity
Constant
Requires Intubation
40-60 mm Hg or below
75 mmHg
No
Severe - 49 or Less
No
EF < 40
Severe > 55
Declined Therapy
Wheelchair
Several

Procedure to Protect Privacy and Confidentiality
Initially, the patient data was to be run by the information technology (IT)

department at SUCH using the search of COPD for the patients from July 2014-July
2019. It was found with data processing that there were very few pulmonary
rehabilitation patients and that a pulmonary rehab patient could fit into more than one

77

category of post-discharge care, especially if the patient were discharged from another

care facility early. This will be considered for a future study. An excel spreadsheet was
initially prepared to extract all variables/covariates determined. An excel sheet was to be
populated by patient medical records when the data was run. Because of the rating scale

developed, the data had to be done by hand with each patient chart for evaluation

purposes.
All patient records were viewed on a secure server at the SUCH only to complete

all data for the project. Any information obtained during data extraction was only

revealed to any researchers listed in this study. The individual patient was identified
initially by medical record number and was secondarily identified using a different
sequential number to identify the patient. The medical number was then be removed,
making the patient de-identified. When the investigator and co-investigators filled in all

variable blocks on the spreadsheet, the data was then analyzed. Any patient identification

was removed for the analysis of data.
All individuals involved in the study had an active involvement in the analysis of

the data information obtained during compilation, and this was done without identifying
the medical record number. Data analysis was used for research purposes only. Any

recorded variables were done within SUCH and on the campus of Cleveland State

University as part of this research. Any data analyzed was done by the investigators listed
on the study only. Each Investigator/Co-Investigator has completed Human Subject
Protection Education (CITI/NIH/Other Ethics Training).

Upon completion of the study, data, medical, and research information was kept
in a locked file drawer in the SUCH cardiac and pulmonary rehabilitation center. It will
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be destroyed using appropriate methods which are secure and environmentally friendly
after the 3 to 5-year expiration. Any publication of data will only use group data and not

identify individuals that were part of the study data. There is no more than minimal risk
to subjects whose information is used in this study. The medical records were only
viewed by small urban community hospital employees and the researchers listed in this

study.

Data Analysis
The data was entered into the Statistical Program for Social Sciences Version 25.0.
Descriptive statistics were used to characterize all included outcome measures. Paired

samples T-test and Crosstabulation Chi-Square test was used to evaluate patient
demographics. An independent samples t-test was performed to determine if the number

of readmissions differed by different post-discharge care settings. A Crosstabulation Chi

Square test was used to compare the post-discharge groups by 30-day readmission status.
The patient history was searched and coded for what discharge care setting the

patient was sent to and did that patient readmit within 30-days of discharge. The four
discharge care settings (HSC, HHC, LTAC and SNF) were evaluated to determine if

there was a sufficient number of patients to be included in the model. A Crosstabulations
dialog was utilized to identify potential independence between the care settings in terms

of proportions of patients who readmitted within 30-days.
The association of post-discharge care setting, and 30-day readmissions was

evaluated using Spearman’s correlation to determine the strength of the relationship.
Bivariate descriptive statistics identified any significant relationship between two

variables utilizing cross-tabulation within a contingency table. A summary of the data is
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provided for each research question. An explanation for each research question will be
given, significance level is p < 0.05.
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CHAPTER IV

RESULTS AND DISCUSSION
Results

The total number of patients admitted with COPD from July 1, 2014, until July 1,

2019, was N=1,016. The total sample used was n=1008 because of 8 patients that had

expired. The demographics are provided in Table 4.1. The population is displayed as
individuals who are readmitted and those who did not readmit. Values are also provided
based on the post-discharge care setting and 30-day readmissions.

Table 4.1 shows on average, the age for all COPD patients had a mean age 64
(±12) years old. The age for those that readmitted was 68.3 (± 10.9) years old. For the
total sample 59% were female and 41% were male. Those that readmitted were 54%
female and 46% male. For the total sample, 77% were black, 22% were white, and 1%
were categorized as “other”. For those that readmitted 75% were black, 28% were white

and 1 % were other. For the total sample and marital status, 548 were single, 287 were

widowed, divorced or other, and 173 were married. Those that readmitted consisted of 85
single, 41 widowed, divorced or other, and 29 were married individuals. Among the total
sample, 559 were on Medicare, 404 were on Medicaid, and 45 had conventional

insurance. Those that readmitted included 82 using Medicare, 67 using Medicaid, and 6
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using conventional insurance. The average length of stay for the total sample was 4.1

days, and the average length of stay for the readmits was 4 days.
Table 4.1 - Patient Demographics for Whole Sample and by Post-Discharge Care

Characteristics

Total Sample
(n=1003)

Total Sample Total Sample 30- HSC30-Day
No Readmit
Day Readmit
Readmit
(n=853)
(n=155)
(n=95)

HHC30-Day LTAC 30-Day SNF 30 Day
Readmit
Readmit
Rea dm it
(n=7)
(n=6)
|n=47)

AGE (mean, t SD)

Age (mean, + SD)

64 (± 12)

64 (±11.36)

68 (± 10.9)

61 (± 10.9)

69 (± 10.1)

67 (± 11.2)

72 (± 10.8)

GENDER
Male

420 - 42%

349 - 41%

71 - 46%

44-46%

20 - 43 %

4-57%

3-50%

Female

588 - 58%

504 - 59%

84 - 54%

51 - 54%

27 - 57%

3 - 43%

3-50%

White

221 - 22%

184-22%

37- 24%

27 - 28%

7-14%

4-57%

0-0%

RACE

Black

773 - 77%

656 - 77%

117 - 75%

67-71%

40 - 86%

3 - 43%

6-100%

Other

14-1%

13-1%

1 - 1%

1-1%

0-0%

0-0%

0-0%

MARITAL STATUS
Single

548

463

85

54

27

2

2

Married

173

144

29

16

9

2

2

Wi dowed/Di vorce d/Oth er

287

246

41

25

11

3

2

INSURANCE
Medicaid

404

338

67

52

13

2

1

Medicare

559

476

82

40

32

5

5

Other

45

39

6

4

2

0

0

4.1

4.1

4

3.22

4.04

7.3

10

13.9

14

14.2

13.3

15.2

14.5

20

Central Cleveland

418

344

74

47

14

7

6

Metro Cleveland

410

348

62

37

25

0

0

Suburban Cleveland

180

161

19

11

8

0

0

608

521

87

55

23

5

4

24

12

0

1

16

12

2

1

LENGTH OF STAY
Average Length of Stay

NUMBER OF DIAGNOSES
Average ft of Ox's

CLEVELAND LOCATION

DISCHARGE LOCATION
Internal Medicine
emal Medicine, Card, Spine,Ger

220

183

37

CMU/ICU/CSU

180

149

31

DISHCHARGE PHYS SPECIALTY
Cardiovascular Disease

132

112

20

12

7

1

0

Internal Medicine

820

688

132

81

39

6

6

Nephrology/Other

56

53

3

2

1

0

0

The average number of diagnoses for the whole sample was 13.9 and for the

readmits was 14.2 diagnoses. For location and the total sample, 418 live in central
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Cleveland, 410 live in Metro Cleveland and 180 live in suburban Cleveland, and among
those that readmitted 74 live in Central Cleveland, 62 live in Metro Cleveland and 19 live

in suburban Cleveland. The discharge location for the total sample was 608 from Internal

Medicine, 220 from Cardiology, Spine or Geriatric, and 180 from CMU/ICU/CSU. Those
that readmitted had the following discharge locations: 87 from Internal Medicine, 37
from Spine or Geriatric, and 31 from CMU/ICU/CSU. The discharge physician specialty

for the total sample was Internal Medicine for 820 patients, Cardiovascular Services for
132 patients and Nephrology/other for 56 patients. For those who readmitted, the
discharge physician specialty was Internal Medicine for 132 patients, Cardiovascular

Services for 20 patients, and Nephrology/other for 3 patients.
Descriptive Statistics

Table 4.2 provides the discharge classifications and 30-day readmissions for the
following categories: home with self-care, home health care, LTAC, and SNF. It also
provides the breakdown of COPD patients as non-readmit and readmit along with the

patient totals. The percentages are also given to demonstrate that those who went to a
SNF had the lowest readmit percentage (10.17%) and those that went to home health care

had the highest percentage at 22.17% of the readmissions.
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Table 4.2 Patient Totals and Percentages with Discharge Dispositions
Facility DC Disposition
Home with Self-Care
Home Health Care
LTAC
SNF
Grand Total

Non-Readmit
584
165
51
53
853

Readmit

Percentage DC Disposition
Home with Self-Care
Home Health Care
LTAC
SNF

Non-Readmit
86.01
77.83
87.93
89.83

Readmit

Total
Patients

95
47
7
6
155

679
212
58
59
1008

13.99
22.17
12.07
10.17

The facility discharge disposition was verified with each claim with the billing
status to the insurance company. There were six instances in which HHC was reclassified

to home with self-care. The patient changing their mind about receiving home health care
deeming it unnecessary, or the home health care agent did not show up promptly, and the

contract was terminated. A comparison was completed by analyzing the original patient
discharge order and the final data statement processed by the insurance company. The

data was adjusted accordingly. There were no other documented changes in patient

records as investigated with each patient during the covariate extraction.
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Table 4.3 Crosstabulation Facility Disposition and Readmission Status
30day Readmit Status

Facility DC
Disposition
Home Self
Care
Home
Health Care
LTAC
SNF
Total

Readmit
within 30
days Count

Readmit
within 30
days
Expected
Count

Total
Count

Total
Expected
Count

574.6

95a

104.4

679

679.0

179.4
49.1
49.9
853.0

47b

32.6

7a
6a
155

8.9
9.1
155.0

212
58
59
1008

212.0
58.0
59.0
1008.0

No
Readmission
Count

No
Readmission
Expected
Count

584a
165a
51a
53a
853

Each subscript letter (a, b) denotes a subset of 30-day Readmit Status categories whose column proportions do not differ
significantly from each other at the .05 level.

Chi-Square
Tests

Pearson
Chi-Square
Likelihood
Ratio
Linear-byLinear
Association
N of Valid
Cases

Value

df

p - value

10.237a

3

0.017

9.694
0.019

3
1

0.021
0.89

1008

a. 0 cells (0.0%) have expected count < 5. The minimum expected count is 8.92

Hypothesis Testing and 30-Day Readmissions

Table 4.3 provides the results from the Chi-Square test of independence that
calculated patients' frequency and facility discharge disposition with 30-day readmission

status. The crosstabulation and Chi-square results revealed that there was significant

difference in proportions between post-discharge care settings. A significant interaction
was found between facility discharge disposition and by 30-day readmit status, (X2 (3) =
10.237, p = 0.017). Patients discharged to home health care (22.17%) were more likely to
readmit within 30-days more than those discharged to home with self-care (13.99%),
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LTAC (12.07%), or SNF (10.17%). The expected cell count for this assumption was met
with 8.92. Results of the chi-square test revealed that there was a significant difference in
proportions between the care settings. Therefore, we reject the null hypothesis of: there
will be no difference in 30-day readmission rates between post-discharge care settings.

A comparison of column proportions was performed to investigate the differences
between care settings further. For these comparisons, the Bonferroni method was utilized

to adjust the p-value based on making multiple comparisons. The column comparisons
showed that the Home Health Care group had a higher proportion of 30-day readmissions

compared to the other discharge settings. No differences were observed in readmission
rates between home self-care, LTAC, and SNF. A post hoc t test was utilized to

determine differences between column comparisons.

Table 4.4 Summary of Primary Hypothesis Statement
Hypothesis
Hal

Ha2

Hypothesis Statement

There will be significant differences in patients who get discharged to
different post-discharge care settings (HsC, HHC, SNF, and LTAC)
who get readmitted within 30 days after index admission with COPD
versus those who do not get readmitted back to the hospital within 30
days of their indexed admission with COPD.
There will be significant differences in the characteristics (covariates)
in patients who get readmitted back to the hospital within 30 days of
their indexed admission and those that do not with COPD.

Conclusion
Accept

Accept

Comparison of Covariates Between Readmits and Non-Readmits
Figures 4.4 represents the covariates that had the most difference according to

those that were readmitted and those that were not readmitted as evaluated by a Chi

square test of analysis from the covariate chart evaluation. Table 4.4 showed that there
were significant differences but not with every variable.
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Table 4.5 COVARIATE ANALYSIS

Variable
Chi Square
3.8
Age
Living Arrangements
1.1
13.5
Length of Stay
8.8
Insurance
Comorbidities
0.8
Home O2
5.7
Previous CAD Disease
30.0
Sleep Apnea
9.7
0.5
Hypertension
19.2
Diabetes
Smoking History
0.5
Sputum
17.4
Cough
6.1
Heart Failure Symptoms
4.9
LABA/ICS
0.6
SaO2
8.1
Weight Classification
5.7
0.8
Wheezing
Severity of Disease
0.7
8.3
Hypoxia
11.5
Hypercapnia
PFT
9.8
FEV1
3.9
5.6
Previous Echo
Systolic Heart Failure
1.1
Right Vent Systolic
2.3
PT/OT
5.1
Adaptive Equipment
6.2
5.5
Exacerbations
*Significant Chi-Square Test (p < .05)

Significance
0.15
0.57
0.001*
0.01*
0.67
0.05*
<0.001*
0.01*
0.80
<0.001*
0.80
<0.001*
0.05*
0.09
0.75
0.02*
0.06
0.69
0.72
0.02*
0.003*
0.01*
0.14
0.06
0.60
0.31
0.08
0.04*
0.05*

The significant variables are presented as proportions of those that readmitted
withing 30-days and those who did not. The red bar graphs make up 100% of those that
readmitted within 30-days and the blue bars represent 100% of those who did not readmit

in a comparison of the scored variable from the covariate chart. The graphs are meant to
compare a patient that readmitted versus the patient that did not.

87

SIGNIFICANT VARIABLES

Figure 4.1 represents the proportion of individuals spending 4 days or less who
readmitted was significantly greater than the proportion that did not. The proportion that
spent 6 days or more who readmitted was significantly less than those that did not readmit

X2 (2, N = 233) = 1.1, p = 0.001. The highest percentage of the readmits stayed four days

or less in the hospital with 69.3% being readmitted. Twenty percent of the readmits stayed
6 days or more. The non-readmits stayed four days or less 48.7% of the time, and 42.0%

of the non-readmits stayed 6 days or more.
The SUCH patients who had a longer length of stay tended to be older, more than

likely to be unmarried, white, lived outside the Central Neighborhood in Metro
88

Cleveland, had more prior hospitalizations, and had a more significant number of
comorbidities. Those patients discharged to a SNF had an average length of stay of 10
days and an average of 20 comorbidities. The readmission rate for these patients was

exceedingly high considering that the average length of stay at SUCH is 4.1 days.
The research suggests that a longer length of stay was associated with an
increased risk for readmissions on a patient-level (Rinne et al., 2017). Figure 4.1 displays
that those patients that readmitted the most had a length of stay of 4 days or less. The

SUCH results refute research results that the longer length of stay is associated with an

increased risk for readmissions (Rinne et al., 2017). Because of the Hospital
Readmission Reduction Program and penalties assessed to a hospital with excessive 30-

day readmissions, the implications for many were that keeping a patient longer in the
hospital would allow more time for the patient to become medically managed and reduce
the risk for readmissions or discharging sooner to inpatient care (HHC, SNF, LTAC)

(Benbassat & Taragin, 2000) (Shah et al., 2016).
Rinne et al., 2017, completed a study on the association between length of stay

and readmission for patients with COPD. With many hospitals, there is a search for ways
to reduce hospital costs. Rinne et al., 2017 indicated that it is unclear as to whether
shortening the length of stay would reduce hospital costs and receive reimbursements or

increasing the length of stay to reduce the chance of 30-day readmissions would reduce
penalties for excessive 30-day readmissions. The confounding variable severity of illness

was associated with a higher rate of readmission, and the results from previous studies
indicate the opposite that those patients that were discharged earlier had a higher rate of

30-day readmissions. There was an unmeasured severity of illness in comparison with
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the length of stay, so it would be difficult to adequately reflect on the results without bias.
Rehospitalization can indicate that there are gaps in follow-up care or the appropriate
discharge care was not selected (Jenks et al., (2009).

From a systems perspective, the patient’s appropriateness for discharge should be
initiated when a patient that is returning to home can fill and self-administer medications,
perform activities of daily living, manage their nutritional needs, and follow-up with their

primary care provided within 7-10 days of hospital discharge (Alper et al., 2019). Putting

a discharge plan into action may increase the length of stay.
The recommendation for the hospital’s appropriateness for discharge would be

considered when there is a collaboration between the care team, the patient, and the
aftercare provider prior to discharge (Mularski et al., 2006). COPD disease-specific

education including, instructions for care and what to do, and who to call if symptoms
worsen has been completed with patient understanding. If the patient lacks

understanding, it should be documented. Medication reconciliation needs to be completed
with all documented meds, and verification of new meds and compatibility of home
medications (Prieto-Centurion et al., 2014). All hospital testing should be processed and

applied to the discharge process. The discharge plan is complete and explained to the
patient, and patient follow-up appointments are scheduled (De Regge et al., 2003). Any
psychosocial barriers, needs for food, medical benefit issues, housing issues, ability to
complete activities of daily living independently, and transportation issues should be

documented, and appropriate referrals should be made with to a social worker (Alper et

al., 2019).
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Figure 4.2 represents the proportion of individuals that had Medicaid insurance
who readmitted was significantly greater than the proportion that did not readmit X2 (2, N
= 233) = 8.8, p = 0. 01. The proportion of individuals that had Medicare insurance who

readmitted was significantly less than the proportion that did not readmit. The highest
percentage of the readmission group represents 52.6% of the group with Medicaid
Insurance, the readmit group had 41.1% of the group with Medicare Insurance. The non
readmit group had 38% of Medicaid Insurance and had 61.3% with Medicare Insurance.

There was a small total for both groups having private insurance.

It has been found that patients 40-64 years old with public insurance of either
having Medicaid or Medicare have the highest readmission rates (Simmering et al.,
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2016). Insurance status is identified as a proxy for socioeconomic status and an identifier
of payer-specific reimbursement for chronic conditions (Press, Konetzka & White, 2018).
Medicaid has a 16.7% rate of readmission, and Medicare has a 14.77% rate. Patients

with private or conventional insurance were 8.25% which is the lowest readmission rate.
The highest percentage readmit group at SUCH is those with Medicaid insurance,

followed closely by Medicare. Simmering et al., 2016 determined the mean predicted
probability of readmission group by Insurance and age group. Since the average age of a

patient at SUCH is 64, the predicted probability of Medicare patients readmitting is
14.77%, Medicaid 16.27%, and private insurance is 8.25% for those under 65 years old.

For those patients, 65 and older, the predicted probability of Medicare patients
readmitting is 11.80%, Medicaid, 10.89% and Private insurance is 10.12%.

Since age was not adjusted in the model, data was used from Table 4.2. For those
patients at such that readmitted within 30-days the average age was 68.3 years old. For
the total sample at SUCH with 30-day readmissions, the results indicate that the Medicaid

group had the highest number of readmissions which refutes Simmering et al., 2016 study
results stating that those patients aged over 64 readmit the most with Medicare insurance.
This could be an indication that a patient may be on Medicaid and is identified as having

a disability due to the advanced stage of the disease and the variability and those that are
eligible for Medicaid or Medicare. The non-readmit group of Medicare supports

Simmering et al., 2016 research that those patients on Medicare insurance may have a

higher level of access to care and have less probability to readmit (Simmering et al.,

2016). It was suggested in the study that interventions should target patients with multi
comorbidity, those that leave the hospital against medical advice, and those discharged to
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home health care (Simmering et al., 2016). The study at SUCH focused on the patient

level factors that should be identified prior to discharge that could alert healthcare

workers as to the type of care that is needed post-discharge.

Figure 4.3 represents the proportion of individuals that used 2L or 3L of oxygen
who readmitted was significantly less than the proportion that did not readmit X2 (3, N =

233) = 5.7, p = 0.05. The highest percentage of readmits is having no home oxygen use

with 54.9%, the non-readmit group had 41.7% with no home oxygen. The readmit group

had 32.7 % of 2 or 3 liters of oxygen at home, and the non-readmit group was 49.0 %.
Both the readmits and non-readmits had 11.0 % of the group using 4 liters or more
oxygen at home.
93

There is evidence supporting the use of supplemental home oxygen in patients
with COPD. Oxygen was the first treatment shown to prolong life in COPD (Stoller et
al., 2009). Typically to qualify for home oxygen therapy, a patient must either have an
arterial blood gas (PaO2) at or below 55 mmHg or an oxygen saturation at or below 88%

taken at rest (Centers for Medicare and Medicaid Services, 2019). Some SUCH patients

meet the recommendations by doing a 6-minute walk test and saturating less than 93%
(Stoller et al., 2009).

Stroller et al., 2009 mentions that it is unclear that the use of 2 to 3 L of home
oxygen with symptomatic COPD patients that have a mild level of hypoxemia and

desaturation with exercise could be beneficial as the SUCH results show fewer
readmissions with 2 to 3 L of home oxygen. Supplemental oxygen at night showed

improvements in patients with COPD. Studies also showed that there are benefits of
oxygen use with the duration of exercise, increased 6-minute walk test distance, reduced

dyspnea, and improved health-related quality of life (Stroller et al., 2009).

Bahadorie and FitzGerald, 2007 indicated that the use of oxygen long-term might
be a risk factor for 30-day readmissions with COPD. Jenks, Williams, and Coleman,

2009 identified oxygen use at home as a patient factor for the readmission of COPD
patients. The Centers for Medicare and Medicaid Services, 2019 found that of 7,206

patients, 7.7% had of patients that had two or more readmissions in 90 days and found
that home oxygen use as a predictor of readmission. Hansen et al., 2013 addressed the

fact that some programs that were developed to reduce readmissions with COPD patients
did not address the use of supplemental oxygen as a factor in readmissions. Silver et al.,
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2017 prespecified risk factors for COPD readmissions and the use of supplemental home
oxygen was presented.

When using supplemental durable medical equipment (DME), there may be

barriers with the patients to receiving supplemental oxygen (Kim et al., 2008). As the
results reflect that not using oxygen as a treatment for COPD had the highest

readmissions at SUCH. Breakdowns in a hospital to home transition in obtaining oxygen

can lead to poor outcomes and sometimes readmission (Thomas L. Petty, 2009). Petty

2009, recognized that it is not just long-term oxygen therapy that can help COPD
patients, that it was also the need to develop an infrastructure within the hospital to
promote collaboration among all stakeholders to translate the evidence into practice

(Skulley et al., 2019). Skulley et al., 2019 recommended the chain of care to a patient
that needs oxygen delivery should include patient identification, patient evaluation,

documentation and prescription, patient education and discharge, home oxygen delivery
and use, patient education at home, revised documentation and prescription, patient
reevaluation (Skulley et al., 2019)
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Figure 4.4 Patients with Coronary Artery Disease by Readmission Status.

Figure 4.4 represents the proportion of individuals that did not have CAD that
readmitted was considerably greater than the proportion that did not readmit. The
proportion of individuals with stable CAD who readmitted was notably less than the
proportion that did not readmit. The proportion of individuals with symptomatic CAD

who readmitted was significantly less than the proportion that did not readmit X2 (3, N =

233) = 30.0, p = 0.001. The readmission group's highest readmits is group 1 (51.3 %),

with not having any documented coronary artery disease. The readmission group with
stable coronary artery disease was 38.1 %, and the symptomatic group had 10.6 % of the

readmission group. Sixty percent of the non-readmit group consisted of those with stable
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CAD, whereas 24% of the non-readmit group had symptomatic CAD. The remaining
16% of non-readmits were those without any known CAD.
There may be a lack of recognition and undertreatment of comorbid coronary

artery disease in COPD patients (Morgan, Zakeri & Quint, 2018). This is demonstrated
by the results of figure 4.4. Because of this, most patients with symptoms of sputum,
cough, and dyspnea upon exertion are treated for COPD. A COPD patient is just as likely

to die from a cardiovascular cause as they are from a disease related to the respiratory
system (Morgan, Zakeri & Quint, 2018). Smoking is the shared risk factor in both

cardiovascular disease and COPD (Sin & Man, 2003). The systemic inflammatory

response associated with COPD puts a patient at risk for CAD.
COPD is described as “the component of the systematic endothelial disease,”

which can cause low-grade chronic systemic inflammation during physiological aging
(Sin & Man, (2003). This systemic aging can simultaneously affect multiple organs, and

it is exceedingly difficult to determine if COPD or CAD came first (Sin & Man, 2003).
Both diseases reveal the same risk factors.

The COPD-related chronic inflammation can contribute to the development and

progress of atherosclerotic plaque formation and progression, precipitated by respiratory
infections and acute exacerbations of COPD, which can induce plaque rupture and

cardiovascular events (Sin & Man, 2003). In this study, it is found that at least 80% of all

patients diagnosed with COPD did not have at least a spirometry test. This is mentioned

because there is considerable overlap between congestive heart failure and COPD in
presenting symptoms (Morgan, Zakeri & Quint, 2018).
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The recommendations for the identification of CVD in COPD patients would be
to consider questioning a patient in assessment with shortness of breath at night, weight

changes, exertional chest pain, and leg pain (Morgan, Zakeri & Quint, 2018). The
physical exam would investigate irregular heartbeats, abnormal breath sounds, and
differences in vascular pulses. The following tests should be performed; EKG, Chest X-

ray, CT scan, echocardiogram, exercise stress test, or a nuclear test (Morgan, Zakeri &

Quint, 2018). The following biomarkers should be evaluated as well to include Troponin

Figure 4.5 Patients with Sleep Apnea by Readmission Status.

Figure 4.5 represents the proportion of individuals at level 1 who readmitted was
significantly greater than the proportion that did not readmit. The proportion of
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individuals at level 2 who readmitted was significantly less than the proportion that did
not readmit, X2 (3, N = 233) = 9.7. More patients that did not have sleep apnea (66.4%)

readmitted, those that used the BIPAP machine readmitted (15.9 %), those that used a
CPAP readmitted 17%. Those that did not readmit with sleep apnea was 45.4% those
that used CPAP did not readmit 32% and those that used a BIPAP 22.7% of the time.

There are an estimated 50 to 70 million Americans that have some sleep

disturbance (CDC, 2020). Males have a prevalence of 10% to 17%, and women have a
prevalence of 3% to 9% for obstructive sleep apnea (Global Initiative for Chronic

Obstructive Lung Disease, 2019). Studies show that 82% to 93% of individuals with
moderate to severe sleep apnea are not aware that they have the condition, and it remains

heavily underdiagnosed (Foldvary-Schaefer, 2019). Patients may not be aware of their
condition because they may not have a controlled environment (Eagan, Knutson, Pereira,
Von Schantz, 2016).
Sardar, Sufyan & Javed, 2019 reflected on the fact that there is a high cost to the

test, unavailability of appointments, and lack of public awareness of the disease. The
graph in figure 4.5 is a clear representation of the readmitted group as almost 70% do not

have sleep apnea. Patients may have sleep apnea but may not have had a sleep study to
diagnose sleep apnea.
Kapur et al., 2017 suggested the following guidelines to a patient that has COPD

with sleep disturbances; the recommendation is very strong to have a home sleep apnea
test, especially if a patient has a cardiorespiratory disease, respiratory muscle weakness,

hypoventilation, chronic opioid medication use, history of stroke or insomnia with
patients that have COPD (Kapur et al., 2017).
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Figure 4.6 Patients with Diabetes on Medication by Readmission Status.

Figure 4.6 demonstrates that the proportion of individuals that did not have
diabetes who readmitted was significantly greater than the proportion that did not
readmit. Over 52.2 % of the readmission group did not have diabetes, whereas 61.7 % of
the non-readmits reported having diabetes with a fasting blood glucose less than 200
mg/dL. Under 20% of both groups reported having diabetes and having their first fasting

blood glucose over 200 mg/dL, X2 (3, N = 233) = 19.2, p = 0.001. The readmission
group had 52.2 % of patients without diabetes, and 25.0 % of the patients had a fasting

blood glucose of less than 200 mg/dL. The readmission group had 31.9 % of the patients
with a first fasting blood glucose greater than 200 mg/dL. The non-readmit group had

their highest population in group 2, with their first fasting blood glucose of less than 200
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mg/dL at 60.4 %. Twenty-five percent had no reported diabetes, and 14.6 % had their

first fasting blood glucose above 200 mg/dL.

With the fact that there are glucose metabolism disturbances in COPD patients,

the research may refute the highest category of readmissions is without diabetes
(Mirrakhivmov, 2012). Centers for Medicare & Medicaid Services, 2019 indicated that

the highest predictive variables for readmissions with COPD patients were emergency
room (ER) visits, cellulitis, myocardial infarction, renal disease, diabetes, and low

education level (CMS, 2019).
Chronic obstructive pulmonary disease is a risk factor for the onset of type 2

diabetes mellitus (Mirrakhivmov, 2012). Studies have suggested that the general

inflammation that influences respiratory disease can be responsible for COPD

development (Mirrakhivmov, 2012). There could be an association with obesity, the
shortage of oxygen (hypoxia), and corticosteroids to reduce the inflammation.
Hyperglycemia can influence the bacterial growth in the airways making a COPD patient

worse (Yam et al., 2010).
Abnormal lung function is associated with an increased incidence of diabetes

(Ford and Mannino, 2004). Depending, on the classification of COPD, patients may have

a higher incidence of diabetes (Ford & Mannino, 2004). The findings from the National
Health and Nutrition Examination study indicated that in the early stage of diabetes there

might be changes in lung function (Ford & Mannino, 2004). Interpretation of the results

of diabetes and readmissions may indicate that those that readmitted the most had a lower
stage of COPD, and those that did not readmit had elevated blood glucose due to the use
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of corticosteroids. Diabetes increases with a worsening GOLD classification score.
COPD is associated with higher rates of diabetes (Glaser & El-Haddad, 2015).

Figure 4.7 Patients with Sputum by Readmission Status.

Figure 4.7 shows that the proportion of individuals with white sputum who
readmitted was significantly greater than the proportion that did not readmit. The
proportion of individuals with yellow sputum who readmitted was significantly less than

the proportion that did not readmit, X2 (2, N = 233) = 1.1, p = 0.001. The figure

represents sputum production which was descriptive by color. Over 62.8 % of the

readmitted group reported having white sputum, 30% of the readmitted group reported
yellow sputum, and less than 10% reported having green sputum. The non-readmit group
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had almost 58.4 % of the patients with yellow sputum, 37.6 % reported having white
sputum, and 7.1 % of those with green sputum.
Chronic cough and sputum production are associated with increased mortality and

COPD exacerbation, especially in smokers (Miravitlles et al., 2000). COPD patients may
not produce sputum with coughing. Patients may not expectorate sputum and may
swallow it. Burgel and Martin, 2010 explained that sputum production might be

intermittent and difficult to evaluate, especially when going from a flare up to remission.

Sputum is also known as mucus hypersecretion (Burgel & Martin, 2010: Fletcher &
Petro, 1976). Stein et al.2012 discussed how sputum production is not dependent on

color on presentation and hospitalization for one or more of any respiratory symptoms.
The results reflect the opposite of what one would expect. However, Melton, 2002

indicated that colored mucous might be an indicator that a patient is a smoker. An
environmental stimulus such as drinking coffee or dark fluids or eating chocolate may
affect the color. Tracking the events prior to color identification may change the

perspective of color, and that color may not be an indicator of severity. Infection, yes but
not the severity (Melton, 2002).

The body’s defense against irritants or pathogens may produce more mucous in
the respiratory tract and therefore have less color but more volume (National Heart, Lung

and Blood Institute, 2020). With the results reflecting the highest readmission with
patients having white sputum, it is safe to assume that there is hypersecretion of sputum
(mucus) and the color is white (Global Initiative for Chronic Obstructive Lung Disease

2019). Those readmissions in the yellow and green may not have as much mucous
production, and this may be because the patient is on corticosteroids to keep the disease
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under control or that the patient has the presence of enzymes from white blood cells in

their mucous, meaning they have an infection (Altiner et al., 2009). The high prevalence
of those having yellow mucous and not readmitting could indicate that antibiotics were

given to treat the condition and the patient did not readmit (Altiner et al., 2009).
Recommendations from Guerrero et al., 2016 would be to collect a
microbiological sample from the patient on the first day of admission to the hospital. An
adequate sample would contain a count of more than 25 leukocytes, and epithelial cells
per field would be less than 10. If a sample could not be obtained, then a nebulizer

device with hypertonic saline would induce sputum production (Guerrero et al., 2016).

Figure 4.8 Patients with Cough by Readmission Status.
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Figure 4.8 represents the proportion of those that readmitted was significantly
greater than the proportion that did not readmit. The proportion of individuals with an
increased cough who readmitted was significantly less than the proportion that did not

readmit, X2 (2, N = 233) = 6.1, p = 0.05. The figure represents the proportion of

individuals with no documented cough who readmitted was 38.1 %, those that had a
reported cough that readmitted 61.1 %. The non-readmits with no cough was 22.8 %.

and with increased cough 75.2%. Those patients that reported a severe cough or
vomiting that readmitted 0.9% and those that did not readmit 2.0 %.

The cough may be hard to differentiate according to its characteristics. Many
patients would not count their coughs in an hour, explain the depth of their cough or how

it makes the patient feel. It may be difficult to quantify a cough for a patient. Cough
evaluation is subjective and not objective (Bhatia & Fromer, 2011). A patient may say,
“it made me vomit” or “pee my pants” as a measure of severity. It was unclear how this

would be documented in a medical record, especially when an intake person is unfamiliar
with the patient. It was challenging to report the statistics since the cough was not
measured.

The results of cough with the category increased cough had a little over 60%

readmission. Several different questions would come into play, such as to what time of
day the assessment was completed (day/night), was it document as coughs per
second/hour/day? (Smith et al., 2003). Because cough is multifactorial and hard to

explain, the increased coughs and the 60% readmission may be due to how the cough is
evaluated in a patient or whether or not the condition developed pneumonia (Pasquale et
al., 2019). The non-readmit group with almost 80% of not being readmitted may have
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causes of increased cough [extra thoracic] due to include effects from medication
including, ACE inhibitors, postnasal drip syndrome, chronic allergic rhinitis, upper
airway cough syndrome, and gastroesophageal reflux (Global Initiative for Chronic

Obstructive Lung Disease, 2019). Other causes of chronic cough [intrathoracic] include
lung cancer, tuberculosis, asthma, interstitial lung disease, left heart failure, and cystic
fibrosis (Global Initiative for Chronic Obstructive Lung Disease, 2019).

The recommendation for healthcare would be to use a validated questionnaire

specifically for a chronic cough to have the patient complete with a clinician upon
admittance. A suggested resource for the study of a cough is the Leicester Cough

Questionnaire (LCQ); it is a valid and reliable measure of health status with those that
have a chronic cough (French, Irwin, Fletcher and Adams, 2002). This questionnaire can

detect changes in cough due to successful treatment (Coyle et al., 2005).
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Figure 4.9 SaO2 During Hospital Admission by Readmission Status.

Figure 4.9 shows that the proportion of individuals with 89% to 93% or less than
3L of oxygen who readmitted was significantly more than the proportion that did not

readmit. The proportions demonstrate that with the progression of COPD or an
exacerbation, oxygen levels become low and readmissions elevate as compared to non

readmits except for the COPD patients with normal SaO2, X2 (2, N = 233) = 8.1,
p = 0.02. Of those that readmitted, 45.1% had 94% to 100% oxygen saturation with
room air, whereas 38% of the readmits had 89% to 93% or less than 3 liters of oxygen.

Seventeen percent of the readmits had SaO2 of less than 89% with greater than 4 liters of
oxygen or CPAP. For the non-readmit group, 64.6 % had 94% to 100% oxygen
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saturation with room air, 24% had 89% to 93% or less than 3 liters of oxygen, and 11%
had SaO2 of less than 89% with greater than 4 liters of oxygen or CPAP.
The normal SaO2 for adults at sea level is 94-98% (Brill & Wadzicha, 2014).
The readmits and non-readmits at level 1 show that on room air the arterial blood is

saturated with oxygen. With the readmits and SaO2, there may be an underdiagnosis of
COPD which is attributed to the early stages of the disease and may not present with
symptoms or with as much intensity as moderate to severe cases (Sandelowsky et al.,

2011). Research has demonstrated that approximately 95% of stage 1 - mild COPD and
80% in stage 2 - moderate COPD remain undiagnosed (Sandelowsky et al., 2011).
The risk factors for being undiagnosed with COPD included having a moderate
reduction in lung function, not having COPD symptoms, and reported being in good

health (Hvidsten et al., 2008). More than one-third of patients admitted to the hospital
with respiratory symptoms and many times are diagnosed with COPD inaccurately

(Spero et al., 2017). Some factors identified in the literature may be discharging a patient
prematurely because of the incorrect index admission, poor medication compliance, lack

of patient and family education regarding COPD, and lack of follow-up with primary care
physician and outpatient rehabilitation program referrals (Benbassat & Taragin, 2000)
Factors that could influence those patients that had 94% to 100% room air oxygen

saturation and readmitted was if a patient was admitted at night, their nocturnal SaO2

would be at the highest percent of a 24-hour period (Brill & Wadzicha, 2014).
The readmits at level 2 and 3 indicates that these patients have a more difficult

time with oxygen getting into their bloodstream. This may be because there is a loss of

lung tissue or airway obstruction (Fletcher & Petro, 1976). Dependent on the time of
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day, SaO2 may fluctuate between day and night (Selfi & Moradi, 2018).

If a patient had

poor circulation, currently uses tobacco, wears fingernail polish, or had artificial nails,
there may be an inaccurate result based on finger pulse oximeters (Lee, Hui, Tan & Lim,
1993). Older subjects may have lower levels of SaO2, have sleep disorder breathing, can

have myocardial ischemia or measurement error (Lee, Hui, Tan & Lim, 1993).
The recommendation for healthcare workers is to review the GOLD guidelines
that have been developed to help clinicians recognize patients with symptoms and help in

the early stages of COPD diagnosis (Global Initiative for Chronic Obstructive Lung
Disease, 2019). These guidelines are very comprehensive and help to confirm an early
diagnosis and improve the management of COPD.
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Figure 4.10 Percent of Hypoxia/Hypoxemia PaO2 by Readmission Status.

Figure 4.10 demonstrates that the proportion of individuals at a normal partial
pressure of oxygen in figure 4.10 at a level of 80 - 100 mmHg who readmitted was
significantly greater than the proportion that did not readmit. The proportion of

individuals at a moderate level of 60 - 80 mmHg who readmitted was significantly less
than the proportion that did not readmit, X2 (2, N = 233) = 8.3, p = 0.02.

The readmit group had 59.0 % at 80-100 mm Hg, 36.1% at 60-80 mm Hg, and
19% at 40-60 mm Hg or below. The non-readmit group was evenly distributed in both
the 80-100 mm Hg and 60-80 mm Hg with 41.0% and 44.0%, respectively, with the

additional 15.8% at 40-60 mm Hg. If there was not a score in the patient medical record,

it was recorded as a normal result, and this may have affected the final result.
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Whether there is low oxygen in the blood (hypoxemia) or low oxygen supply in
the bodily tissues (hypoxia), hypoxemia can cause hypoxia (Porth & Matfin, 2009).

Some of the indications of hypoxia can be physically identified by a physician by
increased respiration, shortness of breath, respiratory distress using intercostal muscles to

breathe, wheezing or crackles, oxygen saturation levels may range from 88 to 92%
(Cukic, 2014). There may be a change in skin color being bluish or gray, and the patient

would not be able to lay flat in bed, unable to speak full sentences, and experience
changes in mental status (Cukic, 2014). When the blood oxygen levels fall below a
certain level, a patient can experience shortness of breath, headaches, confusion, or

restlessness and may indicate hypoxia/hypoxemia (Porth & Matfin, 2009).

The results in group 1 indicate that there are normal cellular metabolism and
normal partial pressure of arterial oxygen. Those in group 2, such as the non-readmits,

may be accustomed to living with a PaO2 less than 80 mm Hg if it is a gradual onset

(O’Driscoll, Howard & Davidson, 2008). The readmits in the range of 60-80 mm Hg,

which occurs suddenly, may be subjected to respiratory failure that may lead to organ
failure (Kong & Wilkinson, 2019). Respiratory failure having PaO2 less than 60 mmHg

can be divided into type I or II depending on PaCO2 (Cukic, 2014).

As Cukic 2014, concluded in her study of airflow limitation, the patients that
received appropriate treatment such as bronchodilator medication and inhaled therapy
along with symptom management being more medically mentioned and have fewer
readmissions with the results of the patients in category 2. Those patients that did not
administer bronchodilator medication and complete their inhaled therapy, manage their
symptoms, and follow up with a physician would have a higher likelihood of
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readmissions (Cukic, 2014). It was also mentioned that those that have had COPD longer

might not respond as well to treatment which could be a cause for readmissions (Cukic,

2014). The number of exacerbations a patient has a year along with bronchial
inflammation will also determine the prevalence of readmissions with COPD patients
(Pauwels et al., 2001)

Those patients in group 3 could be in severe respiratory distress. There will be a
ventilation/perfusion mismatch with this group. The damage of the bronchial mucosa can

lead to the impairment in lung ventilation which can impair gas exchange causing

hypoxemia/hypoxia (Cukic, 2014). Depending on the interventions of supplemental
oxygen through a nasal cannula or through a BIPAP machine, steroids, inhaled

bronchodilators, mucolytics, and respiratory therapy along with the post-discharge care
chosen will determine the likelihood of readmissions (Piper, 2010)

Recommendations to healthcare workers would be to document any comorbid

conditions. Perform a clinical assessment using pulse oximetry an arterial gas analysis

which will quantify arterial partial pressures of oxygen and carbon dioxide and blood pH,
which is the “gold standard” to assess oxygenation (O’Driscoll, Howard & Davidson,
2008). Document physical exam findings of wheezing, nasal flaring, assessor muscle
use, etc. Testing maybe need to be done every 30-60 minutes to resume normal levels

(Cukic, 2014).
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Figure 4.11 Percent of Hypercapnia/Hypercarbia by PcO2 by Readmission Status.

Figure 4.11 shows that the proportion of individuals not having
hypercapnia/hypercarbia who readmitted was significantly greater than the proportion
that did not readmit X2 (3, N = 233) = 11.5, p = 0.003. The readmit group was the highest

in the none/normal category at 57.6 %, whereas those with a PcO2 of greater than 45 mm
Hg was 25.3 %, and 17.2 % of patients readmitted had a PcO2 of 75 mm Hg or higher.
The non-readmit group had 47.4 % with a PcO2 of greater than 45 mm Hg, 16.8 % with a

PcO2 of 75 mm Hg or higher, and 35.8% with a normal PcO2. The patients at SUCH that

readmitted with the highest frequency had normal PcO2 levels. This could indicate that
the test was not completed and scored as having a normal level of CO2 (Cukic, 2014), or

they had normal levels of CO2.
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To diagnose hypercapnia or hypercarbia, a physician needs to order an arterial

blood gas test and examine lung and breathing function. Kong and Wilkinson (2019)

studied the predicted variables for hospital readmissions. It was determined that more
than one comorbidity, previous hospital admission, frailty, and poor nutrition, and lower
socioeconomic status were at the highest risk for readmissions. This could support the

results for readmissions in the normal CO2 group, group 1 (Kong and Wilkinson, 2019).
To identify the presence of an interaction between categorical variables in group 1, an

analysis of variance would need to be tested for more definitive results. For the results

in groups 2 and 3, Bahadori & FitzGerald, 2007, indicated that risk factors for
readmissions include previous hospital admissions, hypercapnia, and patients on oxygen

use long-term. Jenks, Williams, and Coleman, (2009) identified additional patient
factors for the readmission of COPD patients include patients that use oxygen at home,

hypercapnia, comorbidities, systemic corticosteroid use, smoking, and drug use (Jenks,
Williams and Coleman, 2009).
At the moderate level, the proportion of individuals with a PCO2 level greater

than 45 mmHg who readmitted was significantly less than the proportion that did not
readmit. Not everyone with COPD will develop hypercapnia or hypercarbia. If a patient

has more severe symptoms, testing may be performed on a patient, especially if the
patient has bronchitis leading to inflammation and mucus in the airways (Kong &
Wilkinson, 2019). The comorbidities of congestive heart failure, lung cancer, obesity,

depression, diabetes, chronic kidney disease, hypertension, and sleep apnea were all

related to higher rates of readmission (Kong & Wilkinson, 2019). The patient’s objective
biological state of their lungs is sometimes not accurate by the patient’s beliefs, and this
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communication of symptoms may influence how a hospital proceeds with testing
(Kennedy et al., 2017).

Recommendations for patient management from Silver et al., 2017 with COPD
should include respiratory therapy disease management to decrease hypercapnia include,

a discharge program included the relatively low cost (respiratory therapist case
management, subject teaching, written action plan, telephone follow-up), minimal

technology required (telephone), and applicability to a diverse population of subjects with

Figure 4.12 Patients that Completed a Pulmonary Function Test by Readmission
Status. .
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Figure 4.12 shows that the number of individuals that did not have a PFT who
readmitted was significantly less than the proportion that did not readmit, X2 (3, N = 233)
= 9.8, p = 0.01. The readmit group was highest in the category of not having the test
performed at 41.2%. The remainder of the readmitted group was almost 39.0 % having

the pulmonary function test done, and 15.7 % had the test performed within two years of
the visit. The non-readmit group scored the highest in the category of no test performed,

with 64.2 % of the patients not getting a pulmonary function test. The remainder of the
non-readmit group had 30.5 % that had received a pulmonary function test, and 5.3 %

that had completed the test within two years of their visit to the hospital. The pulmonary

function test (PFT) is only performed approximately 20% of the time at SUCH. It should
be noted that when patient scoring was completed there may have been confusion with
the category of completed test (test with completion and no documented date) versus
those that had a test completed within two years (with a documented date).

The PFT declares the severity of disease by the forced expiration of air in one
second (FEV1) (Global Initiative for Chronic Obstructive Lung Disease, 2019).

Spirometry is the gold standard for diagnosing COPD (Global Initiative for Chronic

Obstructive Lung Disease, 2019). COPD is usually not diagnosed until it is in its
advanced stages (Feinberg et al., 2017). Many times, it will go undiagnosed (Hvidsten et
al., 2008). Many patients that have not had spirometry or a PFT are not clinically

diagnosed based on the severity of COPD, which does not follow clinical guidelines

(Stein et al., 2012). A history and physical examination cannot make an accurate clinical
diagnosis of COPD (Spero et al., 2017: Kenealy et al., 2011: Shah, Press, Husingh-

Scheetz & White, 2016: Global Initiative for Chronic Obstructive Lung Disease, 2019).
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If a diagnosis is missed, a patient will not benefit from the appropriate treatment
or be treated for a disease that they do not even have (Gershon et al., 2013). Many of
those patients in the non-readmit group did not have a PFT, possibly because of not

presenting with worsening symptoms (Sandelowsky et al., 2011. Nearly 40% of those in
the readmitted group had a PFT. Depending on when the PFT was performed may give

variance to study results. If the PFT was not done in the last five years, it was not

considered valid (Global Initiative for Chronic Obstructive Lung Disease, 2019).

A clinical diagnosis of COPD is intended to be confirmed by spirometry or a
pulmonary function test (Hyun-Kyoung Koo et al., 2018). In this study, if a patient had a
processed medical claim by their insurance company and it was accepted, the patient

diagnosis was labeled COPD. To have a clinical diagnosis, the FEV1 FVC ratio is < 0.70.

The GOLD guidelines, American College of Physicians, the American College of Chest

Physicians, and the European Respiratory Society of COPD guidelines use < 0.70. This
is fixed regardless of gender, age, and BMI (Global Initiative for Chronic Obstructive

Lung Disease, 2019). Along with spirometry symptoms, the number of exacerbations in

a year must be considered (Montuschi, 2006).
Recommendations to healthcare for completion of a pulmonary function test that
classifies airflow limitation in a COPD patient are described. The existence of a post
bronchodilator Forced Expiratory Volume of Air in one second (FEV1) < 0.70 can verify

the presence of limited airflow along with the patient’s identification of symptoms and

noted exposure to harmful toxins of a COPD patient (Global Initiative for Chronic

Obstructive Lung Disease, 2019). Pelligrino et al., 2005 stated, “Spirometry is the most
accurate and factual measurement of airflow limitation. Spirometry should measure the

117

volume of air forcibly exhaled from the point of maximal inspiration (forced vital

capacity, FVC), the volume of air exhaled in the first second of the test (forced expiratory
volume in one second, FEV1), and the ratio between the forced vital capacity and forced

expiratory volume FEV1/FVC ratio (Pelligrino et al., 2005). The presence of a post
bronchodilator FEV1/FEV < 0.70 confirms the presence of persistent airflow limitation

and determines if a patient has COPD (Pelligrino et al., 2005).

Figure 4.13 Percent of Adaptive Equipment by Readmission Status.

Figure 4.13 demonstrates that individuals who used a wheelchair daily who
readmitted was significantly greater than the proportion that did not readmit, X2 (3, N =
233) = 6.2, p = 0.04. The readmit group had 60.4 %, as documented, with no adaptive
equipment, those having a walker/rollator or a wheelchair, the medical records indicated

a report of 19.8 % in each group. The non-readmit group had 65.7 %, as documented as
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having no adaptive equipment, 26.3 % of those patients that used a walker/rollator and

8.1 % as reported using a wheelchair.
Physical/Occupational therapy is provided at SUCH for patients with COPD.

Activity limitation is a major consequence of dyspnea in COPD patients.

Sociodemographic characteristics may impede the functionality of those with COPD,
especially when living in the central neighborhood surrounding SUCH (Cuyahoga

County Health Needs Assessment, 2016). Because of the abundance of patients using
rollators, having limited green space, and having to use supplemental oxygen, this
prohibits high activity levels and increases the disease's severity (Yam et al., 2010).

Many of the patients, especially in the readmit group, did not receive or refused
physical/occupational therapy during their hospital stay. With the search through the

therapist’s notes, clinicians may have tried to initiate therapy, and the patient was
receiving breathing treatments, or sleeping interventions, and therapy was not completed.

In many cases, it may have been well documented that a patient declined therapy. Recent
illness exacerbation requiring hospitalization and accompanied by a decline in functional

status would receive inpatient physical rehabilitation (Harth, 2009). A patient’s exercise
tolerance is not specifically limited to shortness of breath; it may be due to other
orthopedic issues or fatigue, general, physical, cognitive, or mental (Spruit et al., 2013).

Despite the documented benefits of exercise and the reduction in shortness of breath,

enhanced physical endurance, patients were not using pulmonary rehabilitation, which
created a gap in their quality of health care and may have caused increased 30-day

readmissions (Seamark, Seamark & Halpin, 2007). Most patients are not referred to
pulmonary rehabilitation (Johnston & Grimmer-Sommers, 2010). Linking health care
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professionals such as exercise physiologists, respiratory therapists, nurses, dieticians,

pharmacists, and physicians have demonstrated improved outcomes (Derdak, 2017).
Many SUCH patients decline a 6-minute walk test due to the low levels of physical
activity they have before hospitalization. The 6-minute walk test can be a predictor of

mortality and quality of life (Karanth & Awad, 2017). A specialized pulmonary
rehabilitation program can help with the disease's symptoms and limitations (Spruit et al.,

2013). Unfortunately, there is a low referral rate of patients with COPD to attend
pulmonary rehabilitation at SUCH and across the nation (Johnston & Grimmer-Sommers,

2010).

Adaptive equipment is sometimes necessary with COPD because it restricts mobility

and other activities due to shortness of breath and diminished exercise capacity (Gupta,

Goldstein & Brooks, 2006). A lot of the patients that are admitted to SUCH with COPD

need the use of a walker/rollator or powered wheelchair to get around. As many as 60%
of both the non-readmit and readmit group did not indicate the use of any adaptive
equipment to help with mobility. The wheeled walker is useful when a patient uses a
portable oxygen tank and has to rest when walking short distances and can improve with
walking performance over time (Gupta et al., 2006).

Based on the literature, extra efforts should be made to refer patients to pulmonary
rehabilitation for symptom improvement (Simmering et al.,2016). Pulmonary
rehabilitation should ideally start within 30 days of discharge from the hospital (Johnston

& Grimmer-Sommers, 2010). Spruit et al., 2013 reviewed pulmonary rehabilitation as a

multidisciplinary intervention based on patient assessment followed by an individualized
treatment plan that includes exercise training, education, medication management, and
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self-management of symptoms aiming at behavior change designed to improve COPD’s
physical and psychological conditions (Spruit et al., 2013).

Figure 4.14 Percent of Patients and the Number of Exacerbations by Readmission
Status.

Figure 4.14 shows the proportion of individuals that did not have any previous
exacerbations readmitted significantly less than those that did not readmit, X2 (3, N =
233) = 5.5, p = 0.06. The readmit group had 38.9 % of one exacerbation, 38.9% of

several exacerbations, and 22% did not have an exacerbation in the last year. The non
readmit group reported that 36.7 % did not have an exacerbation in the previous year,

30.6 % had at least one exacerbation in the last year, and 32% had more than one

exacerbation within a year.
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An exacerbation is defined as a flare-up or worsening respiratory symptoms. The

literature identifies that 10 to 55% of readmissions for an acute exacerbation of COPD
may be prevented (Centers for Disease Control and Prevention, 2021). As Montuschi,

2006 suggests, when a patient is treated, they may require antibiotics or corticosteroids
and those patients that listed none in the number of exacerbations were medically
managed whereas those that readmitted were not and therefore were more likely to

require hospitalization (Montuschi, 2006). Pharmacologic therapy is used to reduce the
symptoms of COPD patients and the frequency and severity of exacerbations, and they
also improve health status and the ability to exercise (Montuschi, 2006). Twenty-five

percent of patients with an acute exacerbation of COPD do not recover lung function by
day 30, leaving readmission as an appropriate remedy (Donaldson et al., 2015).

Alfagame et al., 2006, indicated that receiving a pneumonia or influenza
vaccinations were found to significantly reduce the likelihood of a COPD exacerbation.
An exacerbation can last for days or several weeks. As lung function declines,

exacerbations may increase in frequency. Every time this occurs, it leaves behind
irreversible lung damage. Exacerbations can be caused by a lung infection or triggered
by pollutants or situations in which it is difficult to breathe, especially exposure to smoke

(Alfagame et al., 2006).
The data represents a good picture of those that had more exacerbations readmitted

back to SUCH at an increased rate. Having one or several exacerbations increased the
chance of being readmitted within 30 days (Kenealy et al., 2011). It is essential to
understand the causes and reasons for early readmission, such as comorbidities,

hypertension, diabetes, electrolyte disorders, and anemia (Simmering et al., 2016). Stein
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et al., 2012, documented the challenges with the management of COPD indicating, that
hospitals are significantly underestimating the burden of hospitalizations for an acute

exacerbation of COPD (Stein et al., 2012). There has been a lack of evidence to
recommend specific interventions to reduce recurrent 30-day readmissions in those

patients with COPD that have had an acute exacerbation of COPD (Prieto-Centurion et

al., 2014; Shah et al., 2016).

A recommended step is to develop and validate a risk scale to predict better
patient patterns that have readmitted back to the hospital within 30-days. The barriers
associated with low economic status represent a challenge beyond the control of SUCH
and will independently increase the likelihood of 30-day readmissions (Portillo et al.,
2018).
Non-Significant Variables

The first variable from the covariate table was age, and it was evenly distributed
between the non-readmits and readmitted with the highest scores in the 60-80 years old

category. The average age at SUCH admitted to SUCH with a primary diagnosis of
COPD is 64 years old for both males and females. Age is a non-modifiable risk factor
(CDC, 2021). There was a moderate risk for both the readmitted and non-readmitted

patients between ages 60 and 80. COPD often occurs most of the time in older adults

(Bahodori, 2007).

The living arrangements were equally distributed among the non-readmits and

readmitted with the highest score category in those that live alone category. The living
arrangements of the SUCH patients who have COPD were at almost 80% for those that

did not readmit and those that readmitted within 30-days. The quality of the housing and
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conditions associated with poor income may increase the chance of being exposed to
molds, roaches and mites, lead, carbon monoxide and other compounds. Individuals may

be exposed to high temperatures which can lead to adverse health outcomes (Gan et al.,
2017).

The comorbidities of each score category was remarkably similar with groups 1, 2,
and 3. The highest number of both readmits and non-readmits had greater than five

comorbidities in scoring level 3. The second category was 15-20% of having 3 or 4
comorbidities in both groups, and less than 10% of both groups had less than three
comorbidities. Many of the patients at SUCH have multimorbidity which means having

several comorbidities. Having multiple comorbidities can significantly impact health,

health care utilization, and associated costs with healthcare treatment (Stephens & Yew,

2008; Jenks, Williams and Coleman, 2009; Global Initiative for Chronic Obstructive
Lung Disease, 2019; Simmering et al., 2016; Prieto-Centurion et al., 2014).
The covariate group of hypertension on medication was distributed equally with

almost 60% of both the readmits and non-readmits having hypertension with a measure

of 120/80- 140/90 and 30% of both groups above 140/90 and a little over 10% being
without hypertension. Having hypertension is a condition in which the more blood the
heart pumps the narrower the arteries become creating high blood pressure. When the

lungs are damaged there is a reduced amount of oxygen that goes to the blood. The
diseased lung can produce more red blood cells making the blood viscous and harder to

pump which makes a person take on more oxygen by breathing faster (Imaizumi, Eguchi,
& Kario, 2014).
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As expected in the study, smoking and smoking history is one of the leading
causes of COPD. Both groups were close to 40% as having quit for five or more years, or
being a current smoker. Many patients may be unaware that secondhand smoke can be a

contributory factor in COPD development. Many patients or family members smoke in

their homes, and individuals can be exposed during childhood and teenage years which,
slows lung growth and development (Stephens & Yew, 2008). With having limited

education or smoking cessation opportunities, many patients will not be truthful about

how much they smoke (Bantus, 2013). Some of the influences of smoking are mentioned

in lieu of the urban disadvantaged population (Calvillo-King et al., 2013). This includes
occupation, low education level, living in a deprived area, low income, low-income level
due to respiratory diseases, higher frequency of respiratory symptoms such as productive
cough, dyspnea and shortness of breath that affects activities of daily living, airborne

exposure, untreated bronchitis and emphysema, unemployment, manual workers,

communities with a lot of smokers, marital status, lack of insurance, physical impairment,
access to health care, not having a primary care physician, health literacy, seasonal
influences, and the lack of clinical diagnosis of COPD due to patients being a poor

historian or embarrassed about their use of tobacco (Pleasants, Riley & Mannino, 2016),
(United States Public Health Service, 2008) .
Among the covariate of heart failure symptoms on admission, the readmitted

group had the highest percentage of 45% of patients with no symptoms. Approximately
42% had heart failure symptoms on exertion, and 13% had documented orthopnea upon

admission. The non-readmit group had 52% of patients with heart failure symptoms on

exertion, while 30% had no heart failure symptoms, and 18% had reported orthopnea
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upon admission. Heart failure symptoms may reveal themselves as being virtually the
same as COPD. From around 10-40% of patients with heart failure have reported

concurrent COPD because of pathologic changes that can define the clinical presentation
(Hawkins, Virani & Ceconi, 2013).

The covariate group of LABA/ICS drug combination medications had the

readmitted group with taking medications as PRN at almost 70%. The non-readmit group

was slightly above 60%. The readmit group had a little above 20% as non-compliant with
medications, and the non-readmit group had under 20% of non-compliance with

medication. The readmit and non-readmit groups had under 20% of those patients who
did not take LABA/ICS drug combinations.

The most popular medications distributed to patients during a hospital stay is
Ventolin (SABA), Symbicort (LABA), and Atrovent (SAMA). A combination of

Albuterol Sulfate and Ipratropium Bromide may be used and the addition of Symbicort or

LABA/ICS drug combinations (Montuschi, 2006). It has been found that 1 in 10 patients
with a metered dose inhaler performs all the steps correctly (Montuschi, 2006). Patient’s

health beliefs, experiences and behaviors play a big role in the management of
pharmacological therapy (Restrepo et al., 2008).

The covariate weight classification is evenly distributed with the
normal/overweight weight classification; over 40% of the readmits and non-readmits are

ranked in this grouping. The non-readmits were classified at almost 40%, and the
readmits at 25% of the obese category. In the morbidly obese category, the readmits at
nearly 30%, and the non-readmits were a little less than 20%. The weight classification of

patients was equally distributed in both groups. The most prevalent of those that
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readmitted was almost 50% as normal, 25% obese, and nearly 30% as morbidly obese.
There were significantly fewer patients in the non-readmit group that were morbidly

obese at less than 20%. Guo et al., 2016 investigated body mass index and mortality in
COPD, it was shown that those patients that had a BMI in the normal weight category
had a higher risk of death. An increase in BMI was associated with a decreased risk of
death (Guo et al, 2016).

The wheezing covariate was distributed evenly across each level of none,

expiratory and constant wheezing. The most significant group was in the expiratory

group with both readmits and non-readmits at 50%. The readmits at 37% with none and
the non-readmits at less than 35%. The readmits were at 12% with the constant wheezing,

and the non-readmits were slightly higher at 17% of wheezing category groups.

Wheezing is a common and very noticeable symptom of COPD. When wheezing is

absent this does not exclude COPD. Some wheezing may be undetected. Wheezing will
typically occur when COPD is getting worse with worsening shortness of breath,

increased mucous production and cough, headaches, and fever. Dependent of how the
wheezing was assessed and reported in the patient’s chart was documented accordingly.

Physical examination, purse-lip breathing, breath sound intensity, forced expiratory time,

abdominal paradox, Hoover's sign, barrel-shaped chest, accessory muscle use should all
be used for evaluation (Sarkar et al., 2019).

The covariate severity of disease was very equally distributed. Almost 80% of the
patients in both the readmit and non-readmit categories had a nasal cannula while being

admitted to the hospital. Less than 20% of both groups had 4L of oxygen or a CPAP.
Less than 5% of both groups required intubation during their stay in the hospital. Oxygen
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has one of the most value clinical importance factors in the care of COPD in a medical
emergency. Oxygen is given to virtually all patients that are short of breath. Three

reasons oxygen may be used in a hospital environment would be to correct hypoxemia, to

prevent hypoxemia, and is administered because a clinician believes that oxygen can help
reduce breathlessness (O’Driscoll et al., 2008). It is important to consider all factors
when oxygen is administered to COPD patients, those with chest wall problems or those

that have taken opiates (O’Driscoll et al., 2008). The purpose of administering oxygen

therapy is to increase oxygen delivery to the tissues and not to just increase oxygen
carried to the blood (Seifi, Khatony & Moradi, 2018). If a patient is critically ill blood
gases will need to be taken upon arrival to the hospital for assessments of hypercapnia,

hypoxemia and acidosis to determine if a patient needs oxygen therapy (Glouberman et

al., 2017)
With the covariate FEV1., the readmit group that scored the highest was almost

40% in the severe level of 49% or less. Thirty-five percent were at the mild level, which

is greater than 80%. Almost 30% of the readmitted group were at the moderate level of
50-79%. The non-readmit group that scored the highest was almost 45% in the severe

level of 49% or less. Thirty-five percent were at the moderate level, which is 50-79%.

Almost 18% of the non-readmit group were at the mild level in the level greater than
80%.
The forced expiratory volume of air in one second (FEV1) is determined

accurately post-bronchodilator (GOLD, 2020). Any FEV1 determined pre-bronchodilator
to determine GOLD classification may not reflect a bronchodilator response, which could
determine asthma, and this is a reversible disease (Griffiths et al, 1999). The data
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represent only a small sample with less than 30% of patients of both the non-readmits and
readmit groups having a completed spirometry performed. Patients may have had a

completed PFT but there was not a documented FEV1 and whether or not a
bronchodilator was administered during their PFT in their patient chart to have a clearly

defined severity.
In the covariate previous ECHO, the groupings were similar. Both the readmits

and non-readmits were above 60% as a yes, the test was completed. For both the readmits
and the non-readmits, both were close to 20% of being completed within two years of

their visit to the hospital. With the group that indicated no, the test was not performed,
the non-readmit group was slightly above 20%, and the readmitted group was at about
18%. An ECHO is frequently performed in patients with COPD with or without

cardiovascular disease. Approximately 80% of all COPD patients in both the non-readmit

and readmit groups had the test performed as it was used to look for cardiac alterations
and left/right heart disorders (Morgan et al., 2018). Any cardiac issues were self-reported
by the patient. Having a cardiac comorbidity should always be considered with a

diagnosis of COPD (Hvidsten et al., 2008).
With the evaluation of systolic heart failure by ejection fraction, the readmitted

group scored the highest in the normal ejection fraction category with the covariate
systolic heart failure, which would mean 55 - 70 percent, which was 70%. The readmit

group had 20 percent of the patients with an ejection fraction greater than or equal to 40

50%. The readmit group that had less than 40% as an ejection fraction was less than 20%.
The non-readmit group scored the highest in the normal ejection fraction category, which
would mean 55 - 70 percent, at 63%. The non-readmit group had 20 percent of the

129

patients with an ejection fraction greater than or equal to 40-50%. The non-readmit group
that had less than 40% as an ejection fraction was 17%. Because clinical signs and

symptoms of both COPD and congestive heart failure (CHF) overlap both a pulmonary

function test and echocardiography should be performed on every patient (Sin & Man,

2003). Left-sided heart failure can cause fluid buildup in the lungs and exacerbate the
symptoms of COPD (Zulman et al., 2013).
With the covariate right ventricular systolic pressure (RVSP). The readmit group

had 70% of the patients in the mild range of 25-40 mmHg. Almost 30% of the patients
had an RVSP of moderate with a range of 41-55 mmHg. The readmit group had 10% of
those in the severe category with a pressure greater than 55 mmHg. The non-readmit

group had 61% of the patients in the mild range of 25-40 mmHg. Almost 21% of the
patients had an RVSP of moderate with a range of 41-55 mmHg. The readmit group had

18% of those in the severe category with a pressure greater than 55.
Right ventricular systolic pressure is an indicator or pulmonary hypertension

which can be a complication of COPD (Barst et al., 2004). Pulmonary hypertension
develops in 30% to 70% of COPD patients (Barst et al., 2004). Over 60% of the readmits

and non-readmits had normal RVSP. This is a report of only the patients that had a

documented echocardiogram in their medical history. If this was not documented the

patient received a zero in the covariate scoring table. This was an inadequacy of the
study data. Of those patients that had the reported data, almost 20% of the non-readmits
were at the severe range. The “gold standard” for the measurement of pulmonary arterial

pressure is through cardiac catheterization, very few of the patients at SUCH have this

test performed (Barst et al., 2004). Some of the cardiologists that perform an
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echocardiogram may not include the RSVP in the test results.

It would be an important

consideration to screen all clinically diagnosed COPD patients for pulmonary arterial
hypertension in the future for increased treatment of their multi disease condition. It has

been shown that those patients with a RVSP > 55 also had a FEV1 that was severe in
nature (Sim, 2007).
The covariate physical/occupational therapy was the documentation of whether
the patient received physical or occupational therapy during their hospital stay. The
readmit group that scored the highest was no PT/OT completed during their stay and

calculated as 62%. Twenty percent were reported as having active services during their
stay. The readmit group that reported that the patient declined therapy was 18%. The non
readmit group reported from the assessment part of the patient’s medical record that there

was no PT/OT completed during their stay was 50%. Thirty-two percent were reported as
having active services during their stay. The readmit group that reported that the patient

declined therapy was 19%.
The goal for inpatient physical/occupational therapy for a COPD patient is to
maximize their endurance and functional independence (Clini et al., 2009). Patients may

reduce the length of their hospital stay and return home sooner (Seemungal et al., 1998).
Patients take considerable time to recover to baseline levels of their physical functioning
after a COPD exacerbation, with 25% of them who do not fully recover the peak-flow

level after three months after a hospital stay (Clini et al., 2009).
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CHAPTER V

CONCLUSION
The current study explored the 30-day readmission status among the COPD
patients at the small urban community hospital in Cleveland, Ohio. The results of the

current study may be an initial step toward understanding COPD readmissions in the
Central Cleveland area. It encourages more investigation focusing on the readmission

phenomenon in this urban population with COPD. Variables can be identified during

admission using a comprehensive assessment and can be used to create an individualized
discharge plan according to the evaluation of risk with each patient. Upgraded care of the

patients in the hospital and in the community could create a cost savings if discharge
planning is aware of patients at high risk of readmission and the patient is provided
disease specific interventions.

The newly identified patient factors of SUCH acknowledges that the COPD
disease burden is influenced by health-related factors and the socioeconomic,

environmental, cultural, and behavioral characteristics of the patient. From a clinical
perspective, it is incredibly challenging with SUCH because the disease factors interact
with the patient's environmental and social factors. Some factors may underlie with each

patient when two or more conditions exist, especially with how patients with multiple
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conditions view their illness and how that perspective relates to professional medical

treatment (Kennedy et al, 2017).

There were two primary objectives for this study. The first objective of this study

primarily focused on the examination of each post-discharge care pathway chosen and,

which patients readmitted within 30 days. This objective was met and it was found that
HHC readmitted the most within 30-days. The second objective of this study focused on

the characteristics of each patient that readmitted within 30-days individually and by
discharge group. Each patient’s medical chart was examined for demographics,
respiratory symptoms, risk variables, comorbidities, diagnostic groups, hospital testing

and medications and all physician documentation and patient history for the clinical

practice management of each patient diagnosed with COPD. When reviewing the patient
medical charts, each patient was scored by variable according to severity by the listed

numerical documentation.
With the identification of significant variables from this study, a system’s process

can create an awareness with alerts to case management that patients with certain

characteristics can be at risk of 30-day readmission at the Small Urban Community
Hospital (SUCH) with COPD. The future development of a clinical pathway can help
clinicians determine the route of post-discharge care and management of COPD. The

identification of variables to predict readmission, and the determined pathway of care
will promote the adherence to a program to increase the most significant improvement in

the patient’s COPD, improve quality and practice and decrease the financial expenditures

for readmissions (Simons-Morton, McLeroy & Wendel, 2012).
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Both hypotheses were accepted from a research question standpoint. Hypothesis

(Ha1) was accepted because the HHC group readmitted at a higher rate than the other
groups and the second hypothesis (Ha2) was accepted because 48% of the covariates that
were analyzed were statistically different between those that readmitted and those who

did not.
Strengths of This Study

This research study has several strengths as compared to other studies with the

evaluation of 30-day readmissions and post-discharge care. First, this evaluation occurred

in a small, urban community teaching hospital amidst three other larger hospitals, data

was extrapolated with care with this only being a single hospital. This hospital is
considered the downtown hospital in the heart of the central neighborhood in an urban
area with a very diverse population.

Second, to review the post-discharge care accuracy, the records were reviewed

comparing discharge status to that in which the patient was billed and reported to
Medicare/Medicaid and private insurance. The data was reviewed by the clinical

documentation specialists at the hospital before proceeding with data interpretation.
Third, not every patient was clinically diagnosed with COPD. Patients may have

been diagnosed with COPD based on symptoms and smoking history. Many of the
patients with COPD did not have a pulmonary function test to clinically diagnose the
severity of the disease. The degree of accuracy was ensured by verifying that each COPD

patient had a processed and approved claim by Medicare/Medicaid with COPD as the

primary diagnosis for both the whole patient sample and the 30-day readmissions. All
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patient’s, disease diagnoses, and post-discharge care settings were verified through paid

medical claims.

Fourth, the model's framework was used to identify the covariates that would be

most representative to the SUCH patient population, as well as the rating scale used from
1 being mild to 3 being severe based on biologic or numerical markers. All patient

records were reviewed individually to rank the covariates by severity to begin the
development of a post-discharge care plan. Patient medical records were evaluated
individually which allowed the reviewer to get an exact representation of each post
discharge care category and those characteristics that were shown as having the highest

risk level. Previous studies stopped at the investigation of what post-discharge care
setting was chosen and why. This study evaluated the commonalities of the variables in

each setting to create a platform for developing a systematic plan for the discharge

process.
Fifth, this project involved using clinical data generated by healthcare providers,
and the healthcare system to create new knowledge about post-discharge care and
improve outcomes of COPD patients. The researcher worked on translating data into

knowledge and knowledge into a future action plan. One of the goals of this research was
to provide information on characteristics to improve the directive for the coordination of

services and enhance the identification of the best choice of post-discharge care for
COPD patients with identified variables. With the statistical analysis of patient
covariates, this study provided insight into recognition of the characteristics (covariates)
that were presented in the patients that presented a low, medium and high-risk score for

those that did not readmit within 30 days and those that did readmit within 30-days.
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Sixth, A covariate scoring chart was developed from an extensive review of the

literature that used several different predictive models (ADO, BODEX, DOSE, and
LACE) for identifying those individuals at high risk for readmission. The covariate

scoring chart was a model that was developed using 30 different variables. The scored
results gave indications of how the variables measured proportionally with readmits

versus non-readmits by severity.

Seventh, additional information was gained as to the common characteristics with
the patients discharged to all discharge dispositions that readmitted within 30-days and
those that did not. The data from this study provided the building blocks of a model to
evaluate each patient's risk that is diagnosed with COPD. Maintaining efforts to prevent

readmissions at SUCH can be targeted by the known risk factors that may trigger
awareness with each patient’s identified demographics and characteristics.

Limitations/Challenges of the Research Study
This study had some limitations. First, by using patient charts, misclassifications

of patient’s records and characteristics may have been possible when the variable scored
was interpreted into a score. Second, we did not account for some of the patient
information including transportation, severity of disease was determined by what type of
device was used to deliver oxygen because the severity of disease was not declared in the
clinical documentation with spirometry. Third, a lot of the patient symptoms were self

reported and clinically documented and not all testing was completed in the same manner

for each patient. Fourth, because of the relatively small sample size for the post
discharge dispositions of SNF and LTAC a model was not developed to compensate for

the low patient numbers. Fifth, not all the patient data was available for each covariate
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the score for that characteristic was left blank and was not accounted for in the statistical

analysis for the sample size. Sixth, the grouping of 30 variables into 7 categories
(demographics, respiratory symptoms, risk variables, comorbidities, diagnostic group,

hospital testing and medications did not yield a predictive model with the covariates.

Seventh, the covariate comorbidities were represented in the measure by a number (<5, 5
to 10, > 10), to get a more realistic representation of the variable, the identification of the

most frequent conditions that present with a COPD such as cancer, pulmonary vascular
disease and heart disease could have been included in a statistical model to measure the

comorbidity burden. Eighth, some of the variables that had a subjective result instead of
an objective result would need to be changed. For example, cough and sputum. A cough

would need to be verified by a measurement scale and sputum should be measured on
quantity and not colored and the sputum should be evaluated to determine if white blood

cells exist in the specimen.
Future Research
The results were very well represented in the clinical population it serves. This

fact is of great importance with the need to evaluate a patient’s situation, including
demographics, respiratory symptoms, risk variables, comorbidities, diagnostic groups,

hospital testing and medications. The evaluation and recognition of a patient’s clinical

characteristics may give more insight into the patient's overall health. There is a host of
patient-level factors in the urban population independent of their disease pathway, which

may complicate their care and affect patients' outcomes, especially with multiple
comorbidities.
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Due to the lack of clear consensus and clinical guidelines on how best to predict

and prevent readmissions there should be more research in the multifactorial nature of
COPD readmissions especially highlighting multi-comorbidities. The search should
continue for interventions, which are practical, sustainable and suitable for a diverse
population of patients with COPD exacerbations.

Development and testing of the standardization of the clinical content of this

study would prove that the significant variables are indicators for measurement and
feasible for the clinical teams to consider when developing a quality improvement in
clinical care. A Model for Improvement (MFI) could be developed with a step-by-step

approach for best practices in COPD management. Teaching the practices to healthcare

workers and carrying out the system’s processes for testing could use a data driven
approach to effect change in discharge of the patients with COPD.
Conclusions

This dissertation identifies some of the intricate mechanisms involved with COPD
that can heighten the awareness and be pre-identified prior to discharge. It has been

demonstrated that post-discharge care guidelines for HSC, HHC, SNF and LTAC may

need to be developed for patients that have been diagnosed with COPD. Further studies
will be needed to understand the factors involved in discharge planning and patient care

to determine the relative conclusions

The answers to the two research questions in this study can provide information to
clinicians that would normally have common assumptions about how a COPD

readmission patient would look, but this is not always true. The criteria for this study

provided insight into an urban population. This was a look into the characteristics of the
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small urban hospital that has a unique patient population and that it showed that post

discharge care settings matter and there are differences that we can pick up on between

patients that readmit and those who do not. The patient characteristics may not be

explained clinically but through an influence of other factors that would further be
investigated. Clinicians should be educated to take a global approach to identifying

patients that are more risk to readmit within 30-days.
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Appendix D
Covariate Scoring Data Sheet
Covariates to be investigated in COPD patients that readmitted within 30 days ofindexed adnission
Patient
ID
Description
Covariate
Description
Score 1
Score 2

Description

<60

60 - 80

>80

Married
4 Days or Less

Family Sipport
5 Days

6 Days or More

Private Insurance

Only' Medicare

<3

3 or4

Home 02

None

2Lor3L

4L or More

Previous CAD Disease

None

Stable

Symptomatic

Age

Livirg Arrangements
Length of Stay
Insurance

Comorbidities

Lives atone
Medicaid
>5

None

CPAP

BIPAP

NoNormal

120'80 - 14090

Above 140'90

Diabetes on me dication

None

lstFBG< 200 n^ dL

IstFBG >200 mgdL

Smoking History

None

Current Smoker

Sputum

White

Quit 5 years +
Yellow

Cough

None

Increased

SevereVonit

Heart Failure sx on admission

None

On exertion

Orthopnea

LAB A ICS Drug combinations

None

Non-Compliant

Sleep Apnea
Hypertension on Medication

Green

SaO2inlstVS

94% to 100% RA

PRN
89% to 93% or Less than 3L

Weight Classificaton
Wheezing
Severity' of Disease

Normal Overweight
None
Nasal Camila

Obese
Expiratory
4L 02 or CPAP

Constant
Requires Intubation

Hypoxia hypoxemia PaO2

80-100 mmHg

60-80 mmHg

40-60 mm Hg or below

Hypercapnia hyper carbia

None Normal

PCO2>45

Pulmonary Function Test

Yes

Wthin 2 years of visit

75 mmHg
No

Mid - > 80%

Moderate - > 50 - 79%

Yes

Within 2 years of visit

FEV 1

Pre vious Echo

<89% >4LO2 CPAP

Morbid Obesity

Severe - 49 or Less
No

Systole Heart Failure

Normal EF

>40- 50EF

EF<40

Right Ventricular Systolic Pressure

Mild25 -40

Moderate 41-55

Severe >55

PT OTDuring Hosp Stay

None

Active Services

Dedined Therapy

Adaptive Equipment

None

Walker Rolla tor

Wheelchair

Exacerbations in die last year

None

One

Several
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Appendix E

Summary of Groups that Scored Highest with each Covariate
Patient Characteristic

Non-Readmits

Length of Stay
Insurance
Home O2
Previous CAD
Sleep Apnea
Diabetes
Sputum
Cough
Heart Failure Symptoms
SaO2
Hypoxia
Hypercarbia
PFT
FEV1
Systolic Heart Failure
RVSP
PT/OT
Adaptive Devices
Exacerbations

4 Days or Less
Medicare
2L or 3L
Stable
None
1st FBG < 200 mg/dL
Yellow
Increased
On Exertion
94% to 100% Room Air
80-100 mm Hg
PCO2 > 45 mm Hg
None
Severe 49 or Less
Normal Ejection Fraction
Mild 25 - 40 mm Hg
None
None
None
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30-Day Readmissions

4 Days or Less
Medicaid
None
None
None
None
White
Increased
None
94% to 100% Room Air
80-100 mm Hg
None/Normal
None
Severe 49 or Less
Normal Ejection Fraction
Mild 25 - 40 mm Hg
None
None
Several

